{"id":{"0":"nkr7-scx6","1":"r4kb-pc87","2":"62a3-8df5","3":"kkvj-587h","4":"2juy-3evq","5":"7ehz-refy","6":"fsf9-trph","7":"ey8b-ejrf","8":"4day-mt2f","9":"psx4-wq38","10":"fpsi-y8tj","11":"t6u2-f84c","12":"6ryw-hetw","13":"ui6g-vumy","14":"24w5-nppr","15":"uhs4-vv7g","16":"b5wa-ze9s","17":"5dqz-y4ea","18":"3geb-p7nc","19":"d29v-yfc2","20":"8vj7-uiam","21":"xy5u-nzbq","22":"c75w-3h6e","23":"bucw-etpd","24":"nqu5-vn7d","25":"agz7-4mvg","26":"jjpx-mxt8","27":"chnh-3rdi","28":"mpgq-jmmr","29":"c294-dri5","30":"mkyn-icix","31":"a2mg-p2ni","32":"3h4m-i8xf","33":"9ziv-gyv9","34":"xfk2-6xmb","35":"kgid-f54m","36":"wa6b-urfv","37":"xmn2-yrqr","38":"pgaa-i327","39":"8ve6-tiah","40":"338g-fx72","41":"xd2k-siai","42":"2kh7-g39q","43":"kuas-t2xn","44":"235m-gsry","45":"jgkt-w9bh","46":"yu68-juzt","47":"xm7q-e7uu","48":"2se8-zi9r","49":"bwwd-cuna","50":"uk9u-uv8c","51":"rbj6-gv57","52":"rdfw-s4u4","53":"24ct-nyt8","54":"ujph-mgrh","55":"dgwc-f5xf","56":"esmz-a36m","57":"dtz3-sij3","58":"g5ts-294x","59":"iudi-d4pc","60":"4wzk-pwz3","61":"8ggw-jwph","62":"x7xw-nitb","63":"4u7c-2g4q","64":"j63e-g9bn","65":"cygf-tgyd","66":"wepx-mhy6","67":"cuyd-c53m","68":"b68w-a53h","69":"g7ty-3t6s","70":"aian-amjw","71":"aeq9-xksa","72":"b5mu-3rk7","73":"4rd8-s7gn","74":"yp23-fq9k","75":"y93j-qcuq","76":"r9ns-zmra","77":"unxy-rdyx","78":"vagq-bwyc","79":"ef89-9ik2","80":"v6bq-c4f3","81":"re9g-kq7w","82":"mpb9-a9up","83":"6wqg-8ykc","84":"76u3-26ik","85":"b6fe-yq88","86":"5b7j-usbu","87":"k2fe-zny8","88":"gkpu-vawv","89":"mscq-ew9n","90":"gt7a-q73y","91":"ur6f-kidn","92":"64br-p84f","93":"37ui-3igt","94":"eur4-ng38","95":"wtvk-6zfr","96":"hh8a-ys2f","97":"n7uz-829a","98":"phkb-u384","99":"4m2e-y29d","100":"fveu-vvk9","101":"rhwp-grxi","102":"ga52-qyaz","103":"eddk-effy","104":"ndit-r2zk","105":"9kpc-xntn","106":"q8qz-3pb6","107":"adnf-fpem","108":"xqmi-ykpp","109":"5bep-4fv6","110":"ya5p-jf7v","111":"hcxx-dqtx","112":"hyai-856q","113":"c2hx-eeis","114":"h98p-htn6","115":"4ems-va7k","116":"4j6x-nm2a","117":"5y75-rs75","118":"2tj4-nah7","119":"xup8-ahj8","120":"87ea-ip25","121":"ua7e-t2fy","122":"ha59-j5yk","123":"nnvr-zdhw","124":"rv55-x8ff","125":"jj3m-siz7","126":"eg2p-49pd","127":"n2zz-25mk","128":"4bdk-kyzv","129":"si7g-c2bs","130":"94wp-9pid","131":"skkh-jsrk","132":"n97r-u9uh","133":"ker6-gs6z","134":"amjr-ph5r","135":"qr63-vqq5","136":"judz-8etw","137":"vncy-2ds7","138":"h5rx-ppfj","139":"bjpq-vm2t","140":"b6ny-6cd5","141":"ivdz-qhnr","142":"q84f-e68r","143":"3bmy-cyyd","144":"7ym9-zzt7","145":"hea5-6w9c","146":"f3zz-zga5","147":"sumd-iwm8","148":"hmye-mqgq","149":"ahrf-yqdt","150":"uqxy-gepz","151":"ewpg-rz7g","152":"pvk6-8bzd","153":"ph8r-wzxn","154":"9ikp-t8tw","155":"3crz-97tw","156":"gjsp-ircr","157":"aewi-gwni","158":"ysd3-txwj","159":"vdz4-qrri","160":"ndai-i7s4","161":"k4cb-dxd7","162":"xnjn-rdmd","163":"8yup-c35n","164":"eanj-9nie","165":"rdng-ki53","166":"ksfb-ug5d","167":"9cpv-whbv","168":"q9cb-be9u","169":"2m7c-st88","170":"sw5n-wg2p","171":"4g6p-3ed6","172":"8fbp-accd","173":"4giy-47wy","174":"4kn2-jirk","175":"tug7-57z5","176":"ch5i-63ve","177":"m7w3-utaq","178":"vac9-j9wr","179":"b666-c5v5","180":"wj2j-rzx9","181":"55k8-ajvf","182":"bx8m-di6q","183":"n2x4-haas","184":"u22r-ndns","185":"x4dz-rafm","186":"r85e-hjic","187":"6qm2-fbrx","188":"bdyv-z46f","189":"24xb-jxbc","190":"rw4v-h7j9","191":"8zbb-qqwc","192":"tczv-qfsi","193":"h3my-dzpj","194":"bz96-hgr8","195":"n5b3-jati","196":"jbxj-8pnr","197":"bkcm-ybyk","198":"y52v-k5rz","199":"pd5g-36s6","200":"3nnj-6kcn","201":"783t-9j9i","202":"htq2-rqve","203":"jbmi-9jqv","204":"9vgf-r2z6","205":"ugzv-zzdr","206":"xf9s-d895","207":"vfmq-diru","208":"c49c-tp7w","209":"h6vx-wafp","210":"k2e8-8t3h","211":"xx8k-iu94","212":"c7b2-4ecy","213":"hky2-3tpn","214":"7cmc-7y5g","215":"krqc-563j","216":"9umn-c3jf","217":"em5e-5hvn","218":"h3ej-a9ec","219":"5xkq-dg7x","220":"rear-2epk","221":"uiux-mrvg","222":"vr4m-kmk6","223":"rsk5-566a","224":"it4f-frdc","225":"ype6-idgy","226":"aemt-mg7g","227":"jdch-es95","228":"6jg4-xsqq","229":"vyry-2yfg","230":"i7ir-z69g","231":"2574-2pzg","232":"23ai-eekx","233":"4ntf-u76j","234":"48tb-imas","235":"umnb-y23t","236":"vijd-yhjk","237":"k5tv-6cfx","238":"p6r5-duca","239":"jxu8-x79m","240":"4khb-4xch","241":"jnru-aqxk","242":"ut5n-bmc3","243":"7rih-tqi5","244":"367e-pucc","245":"xcc8-2jrh","246":"mvup-dmxz","247":"ijr5-qdv2","248":"p7se-k3ix","249":"g795-gzp9","250":"8kjs-i662","251":"feiy-rryn","252":"xmjk-wh9b","253":"hdja-ybdg","254":"dh32-cnpq","255":"48ev-2ygq","256":"b5qi-b3hv","257":"gpsd-ru5i","258":"pg2r-sfcx","259":"6vwk-ensg","260":"k6sd-3kb8","261":"qdzf-zqgy","262":"vutr-sfkh","263":"8hzs-zshh","264":"sqt4-6a3k","265":"9epi-jrff","266":"dj4t-wmry","267":"p4r5-qsgs","268":"w9cp-q6sg","269":"4892-xxjy","270":"pjb2-jvdr","271":"tqpr-vcrm","272":"7jqv-mu8u","273":"55yu-xksw","274":"9xt5-u42s","275":"mnaa-qctp","276":"6nue-dx9c","277":"be3w-4inw","278":"iqm3-hbev","279":"55uq-699y","280":"brsb-akdp","281":"scrf-8d7w","282":"ku7p-zn4c","283":"wtw5-4wi3","284":"vugp-mqip","285":"exs3-hbne","286":"59vz-u8kg","287":"g2ck-geg5","288":"udwr-3en6","289":"tks5-umwc","290":"s5en-5rpd","291":"sns5-8bg3","292":"s5a6-fn5p","293":"cr56-k9wj","294":"5una-zw6e","295":"7ssk-h5k2","296":"8ame-63pc","297":"rdmq-nq56","298":"kipu-qxy8","299":"hhvg-83jq","300":"yrur-wghw","301":"g4jn-64pd","302":"qfiq-jir6","303":"8jp2-ecz7","304":"sjpm-fk4b","305":"qve4-fp9c","306":"9fpg-7hvw","307":"r229-z6ma","308":"a3gi-4phs","309":"w76m-r924","310":"2nf2-f75n","311":"wwei-z7f5","312":"bkbr-drkm","313":"bst4-hnte","314":"nsxk-tvbw","315":"7mra-9cq9","316":"hksd-2xuw","317":"seuz-s2cv","318":"cf5u-bm9w","319":"ithv-4e9m","320":"yctb-fv7w","321":"5c6r-xi2t","322":"efqg-e273","323":"2v3t-r3np","324":"bumh-rgsq","325":"edkk-ze78","326":"e539-uadk","327":"i6u4-y3g4","328":"gb67-x49c","329":"89qs-mr7i","330":"7xva-uux8","331":"8ucz-ra9b","332":"53g5-jf7x","333":"4bc2-bbpq","334":"9t9r-e5a3","335":"6svj-q4zv","336":"3cxc-4k8q","337":"n5qs-vw3x","338":"bigw-pgk2","339":"5pqj-rvh4","340":"vutn-jzwm","341":"gt5d-asw4","342":"37nu-tuw8","343":"xwa7-cukt","344":"4zxn-f9dq","345":"kmxt-xb3i","346":"v2zw-2d2v","347":"5biu-jjj3","348":"jy4b-8v6u","349":"39z2-9zu6","350":"7dk4-g6vg","351":"hgyx-uuxz","352":"5586-cehn","353":"myzw-mrfh","354":"53z7-6asy","355":"6k6h-dzju","356":"9f67-8jse","357":"6nqh-vaj5","358":"knu9-e7pg","359":"4yy2-qa9v","360":"92ri-yjps","361":"3x54-3thk","362":"9b5z-wnve","363":"hwk8-wu83","364":"bc4h-zh8r","365":"xxzc-cs4a","366":"epbn-9bv3","367":"duw2-7jbt","368":"nw2y-v4gm","369":"gd4x-jyhw","370":"xyst-f73f","371":"shc3-fzig","372":"c76y-7pzg","373":"uuui-fh3m","374":"82ci-krud","375":"4ckf-c7xz","376":"yviw-z6j5","377":"njmz-dpbc","378":"b2qj-y9ew","379":"gvsb-yw6g","380":"qvzb-qs6p","381":"akn2-qxic","382":"767a-qhkg","383":"c2kg-wtx6","384":"r9nv-zxge","385":"h55t-vp3s","386":"wh9j-2zjc","387":"vzr2-2rzq","388":"nauw-t2ir","389":"mbvg-apdj","390":"wibz-pb5q","391":"pmxu-gsdm","392":"u2mu-8h52","393":"dmnu-8erf","394":"bxam-2zsw","395":"pyx3-qe4e","396":"gktn-7mu9","397":"ce73-p89e","398":"grbx-2j68","399":"x66v-w5ka","400":"b8tp-jsmh","401":"38b4-r9iv","402":"2g2d-yfx9","403":"ci7c-73kg","404":"ihtq-qs57","405":"8zhx-mf8r","406":"8na9-qgz7","407":"fvm6-ic5r","408":"u4vw-xsmf","409":"mpx5-t7tu","410":"8hus-y5nc","411":"e2d5-ggg7","412":"vt72-wepb","413":"airz-k28h","414":"dqwm-pbi7","415":"jcn4-jcv5","416":"96sd-hxdt","417":"hf2a-3ebq","418":"p89x-xx88","419":"krhz-spsc","420":"7vg3-e5u2","421":"3daf-8gde","422":"hdx4-e4uu","423":"5u84-m4rs","424":"9ixb-fwvy","425":"ic32-yq9m","426":"mny7-y385","427":"wis9-vyx6","428":"vaca-65fb","429":"ay69-birh","430":"nxu4-tewx","431":"5cg4-4qqe","432":"hrdz-jaxc","433":"kvib-3txy","434":"v22g-tzpk","435":"b6uq-hdgz","436":"ty79-wym3","437":"khic-yj26","438":"dqgu-gg5d","439":"ch83-ush6","440":"jbhn-e8xn","441":"54ys-qyzm","442":"ar8q-3jhn","443":"kvms-atr7","444":"29hc-w46k","445":"ite7-j2w7","446":"iyx3-z4r8","447":"6zuv-bn3z","448":"m35w-spkz","449":"jgk8-6dpn","450":"dt66-w6m6","451":"pwn4-m3yp","452":"ifsm-x42a","453":"cj8b-94cj","454":"q8ig-wwk9","455":"s85h-9xpy","456":"kmvs-jkvx","457":"mb5y-ytti","458":"373s-ayzu","459":"9xb7-9z99","460":"pqpp-u99h","461":"uxgd-cqqc","462":"8dyx-9z99","463":"2den-c3u2","464":"vfj2-bfuw","465":"e5zk-7tx5","466":"9xc7-3a4q","467":"ss2j-8ajj","468":"6mjs-pnrx","469":"pqn7-e45s","470":"ggsw-596z","471":"8wmh-yzz9","472":"i667-sjhg","473":"3pbe-qh9z","474":"52kb-ccu2","475":"qfu5-aeqe","476":"42pu-ymxu","477":"tuza-3b7w","478":"gsea-w83j","479":"ukww-au2k","480":"jmgj-74h4","481":"xcz7-jei9","482":"sv3x-rgz2","483":"mjpe-bnz8","484":"u99h-6e3k","485":"g76d-z8vy","486":"vxpx-d2pt","487":"q78n-cpzf","488":"cjr4-kj3n","489":"53mp-bpbv","490":"rch2-p4nb","491":"gn5f-ec35","492":"nbs2-kemu","493":"xqjn-3jef","494":"mu4v-zehj","495":"m97v-d4fn","496":"66km-38zv","497":"ri74-jp8e","498":"8kbq-i8ii","499":"ycxr-emue","500":"px5t-5gtx","501":"kn6j-fsdu","502":"5i5k-6cmh","503":"pbq2-7wr2","504":"7pvw-pdbr","505":"g653-rqe2","506":"qzjj-q36s","507":"gypc-kpgn","508":"k5dc-apj8","509":"3nnm-4jni","510":"jfbs-8cpp","511":"nmdn-2xuz","512":"3m2r-fh4s","513":"c8as-e7h6","514":"kw6u-z8u2","515":"7b9s-s8ck","516":"uc9k-vc2j","517":"ncvk-7amm","518":"jk8p-fqhn","519":"f3a8-hmpp","520":"3myw-4j4q","521":"3nij-2pw6","522":"cah8-bpvk","523":"bytj-42x7","524":"bw3b-karf","525":"g3c9-wbme","526":"759d-qk63","527":"tfu6-pjxh","528":"hyak-nxqs","529":"82nv-dn3y","530":"uw7a-a5t8","531":"dkyk-v5f5","532":"rcdh-n3ej","533":"xssa-9qw5","534":"6uy5-4d9d","535":"kkix-nh4v","536":"vuhn-dxkt","537":"u2nj-bus9","538":"kxvg-q6s7","539":"wrrd-u9wx","540":"vmgc-uspy","541":"kpbd-vsd5","542":"aspp-bzzu","543":"mr4u-abm2","544":"xvdv-hq7x","545":"rnah-xd9n","546":"fj6i-3v3k","547":"ex65-qa8z","548":"tfcp-ufzp","549":"g6fu-zp23","550":"97bc-2r74","551":"wzwe-859x","552":"sixg-saap","553":"nr42-fsyk","554":"d4v7-r7ct","555":"fztq-uwup","556":"h3kf-bqpq","557":"n322-ce6f","558":"b6sy-qq3u","559":"3svv-v5nh","560":"q8j9-sue7","561":"vqyf-z2g3","562":"5wdd-3g8t","563":"d6p8-wqjm","564":"fdpm-fddm","565":"8nyy-xsq7","566":"2ew6-ywp6","567":"uny6-e3dx","568":"ktba-rcfx","569":"8v6a-z6zq","570":"wxz7-ekz9","571":"25m4-6qqq","572":"gr26-95h2","573":"2vpi-n544","574":"5iuf-feyd","575":"bugr-bbfr","576":"xgy8-wnft","577":"siwp-yg6m","578":"3rge-nu2a","579":"kk8c-wtm4","580":"egm8-9wq7","581":"mawz-airi","582":"dnhi-s2bf","583":"gb4e-yj24","584":"bdsk-unrd","585":"q8xq-ygsk","586":"dv4u-3x3q","587":"ndzg-9nmv","588":"mssc-ksj7","589":"ib3w-k9rq","590":"4ai3-zynv","591":"fbbf-hgkc","592":"wi5c-cscz","593":"mtc3-kq6r","594":"xy7w-35q7","595":"3q3z-9ucr","596":"kp49-9dp8","597":"647a-wjd2","598":"hm3s-vk7u","599":"3qs9-qnbs","600":"42jj-z7fa","601":"6p3a-6xr9","602":"q85u-gmyc","603":"dtm2-meqi","604":"nra9-vzzn","605":"8396-v7yb","606":"muep-c3qd","607":"qz99-wyhv","608":"akkj-j5ru","609":"x9gk-5huc","610":"iwxc-qftf","611":"3j26-kg6d","612":"trpk-sp8z","613":"gxj9-t96f","614":"wpti-gvdi","615":"2na8-fe6s","616":"w4cs-jspc","617":"dmzy-x2ad","618":"xt86-xqxz","619":"9hdi-ekmb","620":"v4tm-h8pe","621":"ssz5-s49e","622":"abgz-qs4g","623":"34p9-h4us","624":"qcw5-4m9q","625":"km4m-vcsb","626":"unsk-b7fc","627":"8xkx-amqh","628":"rh2h-3yt2","629":"jr58-6ysp","630":"9z9x-g48e","631":"en3s-hzsr","632":"8bda-nhxv","633":"uxwq-vny5","634":"95m5-agj4","635":"9y49-tura","636":"jqg8-ycmh","637":"ikd3-vynf","638":"km5s-4339","639":"9gay-j69q","640":"3nzu-udr9","641":"2m93-xvra","642":"9j2v-jamp","643":"95ax-ymtc","644":"nfuu-hu6j","645":"vh55-3he6","646":"xerk-pcm8","647":"8w4j-reb4","648":"h7pm-wmjc","649":"aetd-68ew","650":"ee48-w5t6","651":"ijqb-a7ye","652":"fhky-rtsk","653":"ypxr-mz8e","654":"xmrr-rw5u","655":"5jp2-pgaw","656":"h7xa-837u","657":"tdmv-axfy","658":"jm79-dz78","659":"djj9-kh3p","660":"s5hu-2eck","661":"c4bi-8ytd","662":"ypqf-r5qs","663":"cnd2-a6zw","664":"q9mh-h2tw","665":"a5a8-jsrq","666":"w9g9-rj4y","667":"tt3f-rr33","668":"chcz-j2du","669":"w56u-89fn","670":"hkhc-f7hg","671":"mqmc-4b9n","672":"75vb-d79q","673":"7873-6w4v","674":"jkmz-c8jz","675":"wgvr-7mvz","676":"v2g4-wqg2","677":"2r93-e5cs","678":"w9zu-fywh","679":"ekcb-r85s","680":"d2zt-4m8y","681":"4ueh-89p9","682":"y77q-5ru3","683":"sxbq-3sid","684":"spzz-he63","685":"ke78-phpe","686":"azmd-939x","687":"9kjw-3miq","688":"r5pw-bk5t","689":"tpcp-uiv5","690":"9dzk-mvmi","691":"bxq8-mugm","692":"3ts8-hsrw","693":"n8mc-b4w4","694":"i6ej-9eac","695":"s9qn-46pq","696":"g57i-yx3r","697":"kmap-fsfn","698":"x749-vh2i","699":"egkx-k86t","700":"rsk8-spa7","701":"snev-n7vb","702":"x8ni-jytx","703":"ppmd-3u54","704":"vq7a-fvin","705":"rtjs-ain8","706":"rbrz-y4zd","707":"9x7v-wy9u","708":"6ie8-bpiy","709":"7rci-qmm9","710":"cw4r-vcr3","711":"2vtj-68zm","712":"iu3b-5ngj","713":"9976-4iqj","714":"tdge-ieq8","715":"mcdp-77g7","716":"kebt-3t25","717":"q2dj-esu7","718":"jr4g-zdpg","719":"hbbg-vj7f","720":"9k8a-cbgx","721":"7gnu-j6js","722":"wff4-m3q3","723":"mrip-2k2a","724":"2qxe-cmv4","725":"mwkk-wzmy","726":"w79a-dgrh","727":"chmz-4uae","728":"dp9i-idru","729":"83ng-twza","730":"eudc-n39h","731":"k87d-gv3u","732":"8cyw-fici","733":"9d9z-vf8f","734":"9axm-gjt8","735":"986w-8kut","736":"68sm-zh95","737":"hwyy-s2tt","738":"9kbf-icdi","739":"ngaa-n8ir","740":"hkr7-mcee","741":"h4pd-hu6x","742":"w46e-8kr3","743":"ju63-2fep","744":"b7pe-5nws","745":"q3t8-zr7t","746":"saz5-9hgg","747":"bfqg-cb6d","748":"mbd7-r32t","749":"m74n-4hbs","750":"v5gm-kvkn","751":"28df-2bwy","752":"d2tw-32xv","753":"qdcb-uzft","754":"kee5-23sr","755":"vgc8-iyc4","756":"cwsq-ngmh","757":"yjkw-uj5s","758":"qnzd-25i4","759":"eav7-hnsx","760":"tzyy-aayg","761":"g7hk-rc8d","762":"3sh4-uqpm","763":"swc5-untb","764":"ynw2-4viq","765":"6vqh-esgs","766":"yni7-er2q","767":"y2iy-8irm","768":"w4jm-mysj","769":"th9n-ghnr","770":"8xy9-ubqz","771":"qgkx-mswu","772":"i46a-9kgh","773":"aie4-agrk","774":"65mz-jvh5","775":"ezfr-g6hf","776":"4va6-ph5s","777":"62d6-pm5i","778":"3apk-4u4f","779":"32c3-mvuz","780":"xa4b-4pzv","781":"nr4s-juj3","782":"sf7h-sajc","783":"jwta-jxbg","784":"puzh-5wax","785":"r3zz-ivb8","786":"qfhf-uhaa","787":"g4z9-a9d3","788":"mwk9-wnfr","789":"7xvh-y5vh","790":"9mw4-6adp","791":"k8wy-p9cg","792":"rksx-33p3","793":"u6jv-9ijr","794":"y5bj-9g5w","795":"v2pi-w3up","796":"xb3p-q62w","797":"jb9g-gnvr","798":"8pt5-q6wp","799":"vbim-akqf","800":"vsak-wrfu","801":"qz3x-mf9n","802":"hk9y-quqm","803":"ks3g-spdg","804":"b58h-s9zx","805":"kh8y-3es6","806":"9bhg-hcku","807":"uggs-hy5q","808":"r8kw-7aab","809":"xkkf-xrst","810":"muzy-jte6","811":"3yf8-kanr","812":"kn79-hsxy","813":"pj7m-y5uh","814":"v2k9-ctv4","815":"g3k9-gyw7","816":"qan4-gt4k","817":"igaz-icki","818":"q8w2-qsck","819":"hc4f-j6nb","820":"6pnq-x3ea","821":"qjxm-7fny","822":"ujra-cbx5","823":"v5qq-ktfc","824":"847z-pxin","825":"xm94-zmtx","826":"v76h-zdce","827":"efb8-zbb7","828":"qbrk-85z2","829":"g3g2-srtq","830":"5hvx-krph","831":"7xhe-mv2e","832":"i43m-djm6","833":"4bft-6yws","834":"rezz-ypcg","835":"4ynm-6jgm","836":"pjtk-n43k","837":"v2mh-3yzr","838":"bk9t-cq4b","839":"axsa-zcg5","840":"a93x-tfzm","841":"kyph-4i8d","842":"29xv-7ajw","843":"paqx-33a8","844":"56mi-d4wu","845":"x8jf-txib","846":"mvaf-qxac","847":"smic-9bf9","848":"6kf3-4udg","849":"j6gu-p9yd","850":"52kh-2h7i","851":"247v-f7n9","852":"espg-acwi","853":"m8jv-u92i","854":"4jje-6vv6","855":"dwmy-m9r6","856":"r9mz-pvtk","857":"uu9i-eu7y","858":"ctu5-k6yz","859":"y4ut-ybj7","860":"a9xa-yrhn","861":"u7e4-s8zi","862":"vzfn-ifh5","863":"gepg-djaz","864":"7jik-jwvu","865":"bqmb-vyka","866":"cds4-6y7t","867":"n83i-w4cq","868":"pf7q-w24q","869":"rja3-32tc","870":"k25u-mg9b","871":"88eg-qzed","872":"i8t6-whzd","873":"5h56-n989","874":"66i6-hisz","875":"rpvx-m2md","876":"44rk-q6r2","877":"5avu-ff58","878":"cjin-8pa3","879":"qz67-9a9h","880":"r8hr-3jkm","881":"2i8i-dz8i","882":"u92k-ms37","883":"dy4n-fbwg","884":"mik5-by93","885":"6yz5-ufy2","886":"b6np-zdqj","887":"mv87-mh7a","888":"mvsw-zuaf","889":"fuzh-wm4c","890":"2khz-k7sv","891":"usyq-s7ip","892":"ygrm-jkkz","893":"q9sm-44y3","894":"cqcc-kwwr","895":"d7xj-2da2","896":"bkwy-pyv3","897":"jf8m-mtc3","898":"484g-ihkb","899":"gui6-i83p","900":"rwap-xbst","901":"tv5g-74as","902":"8ezu-y38w","903":"wgyw-mswy","904":"azpx-5hzx","905":"cvcu-witw","906":"h4wb-nae4","907":"qpq4-k3td","908":"6dep-qtzm","909":"w7ew-4aqz","910":"p8ia-4jqj","911":"xsi2-33p5","912":"kx9y-asbg","913":"8rsa-pnhx","914":"qwf3-87ny","915":"fc5f-ixvg","916":"7kht-czfj","917":"9gny-cbhc","918":"ttjk-6u2v","919":"pwgb-7r9t","920":"gp24-kfxi","921":"5nfe-wsjn","922":"7ecz-2gu3","923":"3bix-jq57","924":"i4eq-dgfc","925":"ybum-psnc","926":"qsk4-8yy5","927":"2993-4v7d","928":"ap9g-4wiq","929":"rihk-iawc","930":"5wqm-pm27","931":"hs59-amfp","932":"ht29-hwxw","933":"mi28-ze7h","934":"mkns-9vjv","935":"axgy-8qey","936":"bve7-bjy2","937":"yvsw-8ht9","938":"aagc-37gx","939":"puin-6ss7","940":"hjax-h34q","941":"ehf4-c7tw","942":"62yv-gyiz","943":"drfe-vxdh","944":"xna8-x7qg","945":"fyv2-xffj","946":"y4x9-2nqn","947":"bhxw-k5sb","948":"u7wx-dav2","949":"vx8v-gfyf","950":"qisn-zjv7","951":"bqse-bujd","952":"29js-qshz","953":"khjf-tq2k","954":"wycc-ffia","955":"phwv-i65c","956":"w54d-atna","957":"4t6w-ibvk","958":"r5u4-fzxi","959":"4ewf-ciy6","960":"eez9-q5m5","961":"cz39-ahbn","962":"djk3-k3zs","963":"kucs-wizg","964":"vurf-k5wr","965":"h28b-t43q","966":"fdyw-m38t","967":"spsk-9jj6","968":"xbk2-5i4e","969":"en5r-5ds4","970":"fcqm-xrf4","971":"372p-dx3h","972":"fpqb-s69d","973":"s5vm-cztk","974":"6nbv-ifib","975":"d3c4-tq79","976":"qjju-smys","977":"qjg3-6acf","978":"s2qv-b27b","979":"u3yt-gdfa","980":"vc9m-u7tv","981":"xkb8-kh2a","982":"3h58-x6cd","983":"6tk5-h85s","984":"efpc-rr7b","985":"rxmp-xjpc","986":"ttj2-zsyk","987":"i42d-szcv","988":"6rpz-c2y5","989":"qvvb-s7gu","990":"9qys-crt2","991":"acdz-tk8j","992":"mk6z-83q2","993":"n24i-76tn","994":"x2iq-5477","995":"btcp-84tv","996":"m6gf-vfkz","997":"cucp-zsht","998":"5pe9-px25","999":"fhc9-h3em","1000":"5egk-p6rd","1001":"8n2k-mkiw","1002":"5fyu-rtk3","1003":"p56q-jrxg","1004":"xbxb-epbu","1005":"k56w-7tny","1006":"5mtz-k78d","1007":"9z78-nsfp","1008":"5gu7-u3bj","1009":"su9n-dw6z","1010":"3ahs-wye3","1011":"sesw-5ehn","1012":"wngq-sdai","1013":"sks5-7yq7","1014":"xjhz-wpxi","1015":"u5bf-rqpa","1016":"hmz2-vwda","1017":"4kiq-5hwz","1018":"dkmg-ggf9","1019":"4zc2-9ujh","1020":"k62p-6esq","1021":"biid-68vb","1022":"9g7x-sfq4","1023":"rnvb-cpxx","1024":"vdpk-qzpr","1025":"m5zs-rf6r","1026":"jz7r-jrma","1027":"75b3-73qi","1028":"hwyq-75wu","1029":"scxv-4u4u","1030":"hatw-7gqy","1031":"33kn-dpz2","1032":"9yc3-yir3","1033":"mbsb-z5f8","1034":"swv3-ghj7","1035":"vxsn-2csw","1036":"irpc-yf8f","1037":"gz3p-wzwf","1038":"yakh-mjxn","1039":"7mbm-jety","1040":"xuah-ug7z","1041":"45b4-9j7u","1042":"mhj9-4wi2","1043":"b2jx-uyck","1044":"jqwm-z2g9","1045":"x7zy-2xmx","1046":"n44h-hy2j","1047":"aemk-wcbf","1048":"k86t-wghb","1049":"dxpw-cm5u","1050":"6vp6-wxuq","1051":"nt65-c7a7","1052":"mr8w-325u","1053":"pp7x-dyj2","1054":"489q-934x","1055":"76vv-a7x8","1056":"vba9-s8jp","1057":"735e-byxc","1058":"k8w5-7ju6","1059":"8mrp-rmkw","1060":"hn4x-zwk7","1061":"8hxn-cvik","1062":"at7e-uhkc","1063":"d2rk-yvas","1064":"g9dy-mhts","1065":"k4xj-uge6","1066":"cchw-gdwa","1067":"wrev-kwxu","1068":"9tjt-seye","1069":"ix4g-rt8v","1070":"pkas-xr96","1071":"jbym-fau6","1072":"e92c-t3mi","1073":"xdg2-nh8n","1074":"rpjd-ejph","1075":"sd5c-m3g5","1076":"tj26-bdgd","1077":"6jgb-zrsp","1078":"xv7k-8e7s","1079":"4qb4-rsd8","1080":"bfe6-2gyq","1081":"93k9-hy54","1082":"yqwx-bvu7","1083":"7vnz-2mjz","1084":"afja-b25e","1085":"keia-pvvn","1086":"kikd-77zw","1087":"n835-hpyp","1088":"4y34-2pku","1089":"dwqk-w36f","1090":"pbkm-d27e","1091":"jx6g-fdh6","1092":"yt7u-eiyg","1093":"7pcd-2tnr","1094":"jvf6-ix4w","1095":"6tkz-y37d","1096":"g6qk-ngsf","1097":"hzd8-r9mj","1098":"hdy7-e2a3","1099":"e8kx-wbww","1100":"rg8a-czmp","1101":"s54h-bixi","1102":"89yk-m38d","1103":"isx2-c2ii","1104":"e6fc-ccez","1105":"bi63-dtpu","1106":"krkm-t59m","1107":"qywg-yegp","1108":"i4qp-fnai","1109":"exds-h9fr","1110":"yvdd-g9b2","1111":"sfei-pddr","1112":"4yyu-3s69","1113":"w47j-r23n","1114":"cjae-szjv","1115":"y268-sna3","1116":"mc4y-cbbv","1117":"6rkc-nb2q","1118":"v6ab-adf5","1119":"ddsk-zebd","1120":"epev-k6ss","1121":"3c7d-6fm8","1122":"w9j2-ggv5","1123":"uyzz-86d8","1124":"nwi8-skjj","1125":"2ipe-avu6","1126":"d6kg-4sxv","1127":"vzz2-3hb7","1128":"uac3-ned3","1129":"473a-5348","1130":"vdgb-f9s3","1131":"3kjq-j5dm","1132":"waxm-p5qv","1133":"acme-vg9e","1134":"j32a-sa6u","1135":"cpem-dkkm","1136":"vwmz-4ja3","1137":"9krc-38hs","1138":"g4va-qmeq","1139":"ne52-uraz","1140":"piju-vf3p","1141":"8zea-kwnt","1142":"itia-u6fu","1143":"kwbr-syv2","1144":"wan8-w4er","1145":"vbct-2pi3","1146":"jz6n-v26y","1147":"qcai-zfj9","1148":"8235-5d73","1149":"ei7y-3g6s","1150":"tkjk-cwh5","1151":"q9tu-7yha","1152":"3hwj-hqmh","1153":"u93h-quup","1154":"dnxe-zgxs","1155":"u76f-m89e","1156":"xyxp-dxa9","1157":"uarv-cqnu","1158":"pj7z-f3xf","1159":"akmt-4qtj","1160":"vr6p-ert2","1161":"4ya2-fkvt","1162":"qwpv-wpc8","1163":"57qw-ifet","1164":"x6ag-8y7r","1165":"5hns-mwci","1166":"4xf6-nrwk","1167":"xvu4-xjdb","1168":"ese6-rqpq","1169":"smai-7mz9","1170":"2389-pvg9","1171":"h6kq-aiu7","1172":"5amh-5sx3","1173":"68zh-tyt3","1174":"fip8-rcng","1175":"f8gx-sdye","1176":"4tmr-eik2","1177":"sgg4-hiwe","1178":"p8tr-pquj","1179":"5qag-uzp2","1180":"x7ys-5vpn","1181":"ezab-8sq5","1182":"f2gw-2eas","1183":"8s4r-kzwb","1184":"f6ee-eq37","1185":"j9id-xrm6","1186":"pb4z-432k","1187":"7esm-uptm","1188":"r7hc-32zu","1189":"nf22-99pv","1190":"ekd3-qu3w","1191":"n3wf-wtep","1192":"d6kj-devz","1193":"d69q-iyrb","1194":"7pb7-w9us","1195":"ydsy-yh5w","1196":"65xe-6neq","1197":"mpdg-hf57","1198":"9n3x-apcd","1199":"97tt-n3j3","1200":"s5s8-d82d","1201":"rkpp-igza","1202":"pib3-gftc","1203":"msjj-a7q2","1204":"fkfk-2j5x","1205":"iz46-hpaa","1206":"y8pa-p62q","1207":"4r49-eadb","1208":"26a7-nc4u","1209":"vqff-ff7g","1210":"hauf-e9a4","1211":"hget-9fst","1212":"6tmq-h6uy","1213":"7zky-in8p","1214":"i9qr-47vu","1215":"a37y-w96i","1216":"pvr7-gpk4","1217":"9w38-t35p","1218":"5p6r-d32s","1219":"azgh-hvnt","1220":"bjsc-yd7n","1221":"g4ag-jrdn","1222":"e8fc-yrqd","1223":"x9gq-59r3","1224":"3se3-rwj2","1225":"3bjr-fr6m","1226":"ea3z-m7eh","1227":"k9ai-xgx2","1228":"68ej-h5ze","1229":"28km-nz6e","1230":"pvxp-wfpg","1231":"bptw-uw4i","1232":"ksf9-pem2","1233":"2snk-eav4","1234":"hj2x-85ya","1235":"5nuu-6upy","1236":"xsu4-4sk9","1237":"8i5t-42wz","1238":"u5yv-9uts","1239":"8ihh-n7ic","1240":"6i2x-3kw3","1241":"rb93-4tgj","1242":"29ew-qk7z","1243":"fj6s-ssz6","1244":"an65-3p9b","1245":"s9bp-7k3m","1246":"rmzv-dc5f","1247":"ebbj-sh54","1248":"haed-k2ka","1249":"rqg5-mkef","1250":"m26b-i3pr","1251":"tbyb-bvjd","1252":"vtt8-av2v","1253":"66cx-b9a4","1254":"equ4-92qe","1255":"7dvv-y64a","1256":"tid6-xphm","1257":"e9r5-5hjr","1258":"2sxq-n8zu","1259":"vw7y-v3uk","1260":"7njk-uncd","1261":"t3tz-gvpr","1262":"ebcc-3d5i","1263":"a5h2-p2dw","1264":"ubjb-j2zi","1265":"32fd-hyzc","1266":"yhkp-cczf","1267":"xsta-sbh5","1268":"eb4y-d4ic","1269":"hgv5-3wrn","1270":"hp6w-4ap6","1271":"2dwv-vfam","1272":"hhew-mxbt","1273":"wpkd-y6hn","1274":"8qgt-54j8","1275":"ffbi-is3j","1276":"7nwe-3aj9","1277":"escb-scz6","1278":"wcfv-gpn6","1279":"2nim-maxh","1280":"pq9e-uf4u","1281":"83hz-w2t5","1282":"vm4m-idi8","1283":"n4v6-56e8","1284":"ntaa-dtex","1285":"rppv-wbiv","1286":"pxa6-asqb","1287":"b4av-siev","1288":"45um-c62r","1289":"nq6q-szvs","1290":"wcwi-x3uk","1291":"ig4m-ub43","1292":"fqve-8wzt","1293":"52cr-rw4k","1294":"8rkx-vimh","1295":"y6uv-t34t","1296":"23gt-ssfe","1297":"rg4j-6mcc","1298":"9ix3-ryt6","1299":"edtz-vibe","1300":"b36e-ru3r","1301":"qz8t-eu2e","1302":"5ekf-pmct","1303":"ya9m-pyut","1304":"nkri-ptxd","1305":"crtu-weni","1306":"vp9c-m6nq","1307":"m4es-3af4","1308":"bbhn-4mdn","1309":"t984-9cdv","1310":"wnjn-mave","1311":"rq85-buyi","1312":"mmi4-8ajr","1313":"8zak-ewtm","1314":"j8jk-5ztv"},"name":{"0":"Cumulative Influenza Vaccination Coverage, by Flu Season and Race\/Ethnicity, Pregnant Women 18-49 years","1":"Assessment of Filtration Efficiency, Manikin Fit Performance, and Strap Performance for Decontaminated N95 Filtering Facepiece Respirators","2":"Inconsequential Role for Chemerin-Like Receptor 1 in a Manifestation of Ozone-Induced Lung Pathophysiology in Male Mice","3":"Effects of inhaled tier-2 diesel engine exhaust on immunotoxicity in a rat model:  A hazard identification study. Part III. Immunotoxicology","4":"Release of Crystalline Silica Nanoparticles During Engineered Stone Fabrication","5":"Nerve agent exposure and physiological stress alter brain microstructure and immune profiles after inflammatory challenge in a long-term animal model of Gulf War Illness","6":"Comparative in vitro toxicity of different thermal spray particulates in human bronchial cells","7":"2021 Final Assisted Reproductive Technology (ART) Success Rates","8":"Mapping Injury, Overdose, and Violence - Census Tract","9":"Mapping Injury, Overdose, and Violence - County","10":"Mapping Injury, Overdose, and Violence - State","11":"Mapping Injury, Overdose, and Violence - National","12":"2021 Final Assisted Reproductive Technology (ART) Patient and Cycle Characteristics","13":"2021 Final Assisted Reproductive Technology (ART) Services and Profiles","14":"2021 Final Assisted Reproductive Technology (ART) Summary","15":"Assessment of dermal sensitization by nickel salts in a novel humanized TLR-4 mouse model","16":"CDT_INDIVIDUAL_LINEAGES_BY_WEEK_LOCAL_PIVOTED","17":"CDC Epidemic Trends and Rt","18":"CDT_INDIVIDUAL_LINEAGES_BY_WEEK_LOCAL","19":"Shoulder-Assist Exoskeleton Effects on Balance and Muscle Activity During a Block-laying Task on a Simulated Mast Climber","20":"Characterizing dynamic atmosphere generation system performance for analytical method development","21":"Applied pressure alters circulating hormone levels and biomarkers of peripheral vascular, sensorineural dysfunction","22":"A High-throughput, Turbulent-mixing, Condensation Aerosol Concentrator for Direct Aerosol Collection as a Liquid Suspension","23":"Rat-Tail Models for Studying Hand-Arm Vibration Syndrome:  A Comparison between Living and Cadaver Rat Tails","24":"Weekly Cumulative RSV Vaccination Coverage, by Race and Ethnicity, Medicare Fee-For-Service Beneficiaries aged \u226575 years and enrolled in a Part D plan, United States, Data Source: Centers for Medicare & Medicaid Services Chronic Conditions Warehouse","25":"Weekly Cumulative Influenza Vaccination Coverage, by Flu Season and Race and Ethnicity, Medicare Fee-For-Service Beneficiaries aged \u226565 years, United States, Data Source: Centers for Medicare & Medicaid Services Chronic Conditions Warehouse","26":"Weekly Cumulative COVID-19 Vaccination Coverage, by Season and Race and Ethnicity, Medicare Fee-For-Service Beneficiaries aged \u226565 years","27":"Efficacy of powered air-purifying respirators (PAPRs) for source control of simulated respiratory aerosols-dataset","28":"Weekly Hospital Respiratory Data (HRD) Metrics by Jurisdiction, National Healthcare Safety Network (NHSN) (Preliminary)","29":"Trends in Worker Hearing Loss by Industry Sector, 1981-2010","30":"Economic Burden of Occupational Fatal Injuries in the United States Based on the Census of Fatal Occupational Injuries, 2003-2010","31":"Prevalence of Hearing Loss in the United States by Industry, 2000-2008","32":"Circular RNA hsa_circ_0008726 Targets the hsa-miR-206-3p\/KLF4 Axis to Modulate 4,4\u2019-Methylene Diphenyl Diisocyanate-Glutathione Conjugate-Induced Chemokine Transcription in Macrophages","33":"Factors affecting chlorinated product formation from sodium hypochlorite bleach and limonene reactions in the gas phase","34":"Systemic and immunotoxicity induced by topical application of perfluoroheptane sulfonic acid (PFHpS) or perfluorooctane sulfonic acid (PFOS) in a murine model","35":"Evaluation of A Passive Back-Support Exoskeleton during In-Bed Patient Handling Tasks","36":"Compact, High-flow, Water-based, Turbulent-mixing, Condensation Aerosol Concentrator for Collection of Spot Samples","37":"Quantification of mechanical behavior of rat tail under compression","38":"Systemic and immunotoxicity induced by topical application of perfluorohexane sulfonic acid (PFHxS) in a murine model","39":"Persistence of SARS-CoV-2 on N95 filtering facepiece respirators: implications for reuse","40":"Testing the shock protection performance of Type I construction helmets using impactors of different masses","41":"Potent Lung Tumor Promotion by Inhaled MWCNT","42":"Exposure to emissions generated by 3-dimensional printing with polycarbonate affects vascular morphology and expression of markers of oxidative stress and vascular dysfunction in cardiac tissue","43":"MicroRNA-Mediated Kr\u00fcppel-Like Factor 4 upregulation Induces Alternatively Activated Macrophage-Associated Markers and Chemokines Transcription in 4,4\u2019-Methylene Diphenyl Diisocyanate Exposed Macrophages","44":"Pulmonary evaluation of whole-body inhalation exposure of polycarbonate (PC) filament 3D printer emissions in rats","45":"The effects of diesel exhaust inhalation on cardiovascular function","46":"Anthropometry of Law Enforcement Officers","47":"Applied force alters sensorineural and peripheral vascular function in an animal model of hand-arm vibration syndrome","48":"Lung toxicity, deposition, and clearance of thermal spray coating particles with different metal profiles after inhalation in rats","49":"Optimization of Aspergillus versicolor culture and aerosolization in a murine model of inhalational fungal exposure","50":"4,4\u2019-Methylene Diphenyl Diisocyanate Exposure Induces Expression of Alternatively Activated Macrophage-Associated Markers and Chemokines Partially Through Kr\u00fcppel-Like Factor 4 Mediated Signaling in Macrophages","51":"Developing a Solution for Nasal and Olfactory Transport of Nanomaterials","52":"Characterization of a multi-stage focusing nozzle for collection of spot samples for aerosol chemical analysis","53":"NPPTL Filtering Facepiece Respirators with an Exhalation Valve: Measurements of Filtration Efficiency to Evaluate Their Potential for Source Control","54":"Health conditions among male workers in mining and other industries reliant on manual labor occupations: National Health Interview Survey, 2007\u20132018","55":"DPM OC, EC and FT-IR data (Quantifying elemental and organic carbon in diesel particulate matter by mid infrared spectrometry).","56":"Fit evaluation of NIOSH Approved N95 filtering facepiece respirators with various skin protectants: a pilot study","57":"Inhalation of polycarbonate emissions generated during 3D printing processes affects neuroendocrine function in male rats","58":"High-Fat Western Diet Alters Silica-induced airway epithelium ion exchange but not airway smooth muscle reactivity","59":"Multi-Walled Carbon Nanotubes Induce Arachidonate 5-Lipoxygenase Expression and Enhance the Polarization and Function of M1 Macrophages in vitro","60":"A Projectile Concussive Impact Model Produces Neuroinflammation in Both Mild and Moderate-Severe Traumatic Brain Injury","61":"Examination of the exposome in an animal model: the impact of high fat diet and rat strain on local and systemic immune markers following occupational welding fume exposure","62":"Systemic toxicity induced by topical application of perfluoroheptanoic acid (PFHpA), perfluorohexanoic acid (PFHxA), and perfluoropentanoic acid (PFPeA) in a murine model","63":"Influence of Impurities from Manufacturing Process on the Toxicity Profile of Boron Nitride Nanotubes","64":"Agreement of hip kinematics between two tracking marker configurations used with the 1 CODA pelvis during ergonomic roofing tasks","65":"Persisting Cryptococcus Yeast Species Vishniacozyma victoriae and Cryptococcus neoformans Elicit Unique Airway Inflammation in Mice Following Repeated Exposure","66":"Exposure to the immunomodulatory chemical triclosan differentially impacts immune cell populations in the skin of haired (BALB\/c) and hairless (SKH1) mice","67":"Correlation between graphitic carbon and elemental carbon in diesel particulate matter in workplace atmospheres-Dataset","68":"NanoSpotTM Collector for Aerosol Sample Collection for Direct Microscopy and Spectroscopy Analysis-Dataset","69":"Efficacy of Do-It-Yourself Air Filtration Units in Reducing Exposure to Simulated Respiratory Aerosols","70":"Biological effects of inhaled crude oil vapor. III. Pulmonary effects","71":"Lung toxicity and gene expression changes in response to whole-body inhalation exposure to cellulose nanocrystal in rats","72":"Exposure to the antimicrobial chemical triclosan disrupts keratinocyte function and skin integrity in a model of reconstructed human epidermis","73":"\u03b2-defensin-1 regulates influenza virus infection in human bronchial epithelial cells through the STAT3 signaling pathway","74":"Constant vs. cyclic flow when testing face masks and respirators as source control devices for simulated respiratory aerosols","75":"Biological effects of inhaled crude oil vapor VI. Altered biogenic amine neurotransmitters and neural protein expression","76":"Feasibility of a Selective Epoxidation Technique for Use in Quantification of Peracetic Acid in Air Samples Collected on Sorbent Tubes-Dataset","77":"Evaluation of Propylene Glycol Methyl Ether as a Potential Challenge Agent for Leak Detection of Liquid and Headspace from Closed System Drug Transfer Devices using Fourier Transform Infrared Spectroscopy","78":"Elevated muscle mass accompanied by transcriptional and nuclear alterations several months following cessation of resistance-type training in rats","79":"Interleukin-11 Receptor Subunit Alpha-1 is Required for Maximal Airway Responsiveness to Methacholine After Acute Exposure to Ozone","80":"Effects of whole-body vibration on reproductive physiology in a rat model","81":"In vivo and in vitro toxicity of a stainless-steel aerosol generated during thermal spray coating","82":"Evaluation of pulmonary effects of 3-D printer emissions from acrylonitrile butadiene styrene using an air-liquid interface model of primary normal human-derived bronchial epithelial cells","83":"Automated oil vapor inhalation exposure system","84":"Video-Based 3D pose estimation for residential roofing-dataset","85":"A Field-Portable Colorimetric Method for the Measurement of Peracetic Acid Vapors: A Comparison of Glass and Plastic Impingers","86":"Lung Toxicity Profile of Inhaled Copper-Nickel Welding Fume in A\/J Mice","87":"Pulmonary toxicity and gene expression changes in response to whole-body inhalation exposure to multi-walled carbon nanotubes in rats-Dataset","88":"Biological effects of crude oil vapor. IV. Cardiovascular effects-Dataset","89":"Evaluation of the fall protection of Type I industrial helmets","90":"Revealing the Structural and Chemical Properties of Copper-based Nanoparticles Released from Copper Treated Wood-Dataset","91":"Development of a thermal spray coating aerosol generator and inhalation exposure system","92":"Dermal exposure to the immunomodulatory antimicrobial chemical triclosan alters the skin barrier integrity and microbiome in mice","93":"Systemic toxicity induced by topical application of heptafluorobutyric acid (PFBA) in a murine model","94":"High-fat western diet consumption exacerbates silica-induced pulmonary inflammation and fibrosis","95":"Efficacy of Portable Air Cleaners and Masking for Reducing Indoor Exposure to Simulated Exhaled SARS-CoV-2 Aerosols \u2014 United States, 2021","96":"Reduction of exposure to simulated respiratory aerosols using ventilation, physical distancing, and universal masking","97":"Face mask fit modifications that improve source control performance dataset","98":"Modeling Neuroimmune Interactions in Human Subjects and Animal Models to Predict Subtype Specific Multidrug Treatments for Gulf War Illness","99":"MicroRNA-Mediated Calcineurin Signaling Activation Induces CCL2, CCL3, CCL5, IL8 and Chemotactic Activities in 4,4\u2019-Methylene Diphenyl Diisocyanate Exposed Macrophages","100":"Effects of E-Cigarette Flavoring Chemicals on Human Macrophages and Bronchial Epithelial Cells","101":"Weekly Hospital Respiratory Data (HRD) Metrics by Jurisdiction, National Healthcare Safety Network (NHSN) (Historical)","102":"Efficacy of ventilation, HEPA air cleaners, universal masking, and physical distancing for reducing exposure to simulated exhaled aerosols in a meeting room-Dataset","103":"The \u03b2-adrenergic receptor blocker and anti-inflammatory drug propranolol mitigates brain cytokine expression in a long-term model of Gulf War Illness","104":"Source Apportionment and Quantification of Liquid and Headspace Leaks from Closed System Transfer Devices via Selected Ion Flow Tube Mass Spectrometry (SIFT-MS)","105":"Controlled Generation of Peracetic Acid Atmospheres for the Evaluation of Chemical Samplers","106":"Efficacy of universal masking for source control and personal protection from simulated respiratory aerosols in a room","107":"Influenza virus induced novel miRNAs regulate the STAT pathway","108":"Effects of Crystalline Silica Inhalation in a High-Fat Western Diet","109":"Effects of antimicrobial chemical exposures on influenza vaccination and antiviral immunity","110":"Antimicrobials and Allergic Disease: Identifying Novel Biomarkers and Mechanisms of Action","111":"Resolution of Pulmonary Inflammation Induced by Carbon Nanotubes and Fullerenes in Mice: Role of Macrophage Polarization","112":"A model for detecting the effects of vibration on peripheral blood flow","113":"NIOSH Anthropometric Data and ISO Digital Headforms","114":"Effects of Welding Fume Exposure on Human Placental Cells","115":"Total Inward Leakage (TIL) for Respiratory Protective Devices","116":"Projectile Fluid Penetration and Flammability of Respirators and other Head\/Facial Personal Protective Equipment (FPFPPE)","117":"Respirator Performance against Nanoparticles under Simulated Workplace Activities Data","118":"Anthropometric Database for the EMTs in the United States","119":"Firefighter Body Dimensions for Updating Safety Specifications for Fire Apparatus and Firefighter Protective Equipment","120":"NIOSH Health Hazard Evaluation Program Noise Measurement Database","121":"Weekly Hospital Respiratory Data (HRD) Metrics by Jurisdiction, National Healthcare Safety Network (NHSN)","122":"Deepwater Horizon Response Air Sampling Data","123":"An Investigation Into the Relationship Between Coal Workers\u2019 Pneumoconiosis and Dust Exposure in U.S. Coal Miners","124":"Prevalence of Pneumoconiosis and its Relationship to Dust Exposure in a Cohort of U.S. Bituminous Coal Miners and ex-Miners","125":"Gene Expression Profiles of Di-n-butyl Phthalate in Normal Human Mammary Epithelial Cells","126":"Applied force alters sensorineural and peripheral vascular function in an animal model of hand-arm vibration syndrome","127":"Monthly Cumulative Number and Percent of Adults 75 Years and Older Who Received 1+ RSV Vaccination Doses by Jurisdiction, United States","128":"Monthly Cumulative Number and Percent of Children <8 Months Who Received Nirsevimab by Jurisdiction, United States","129":"National Immunization Survey Adult COVID Module (NIS-ACM): RespVaxView| Data | Centers for Disease Control and Prevention (cdc.gov)","130":"Vaccination Concerns, Issues, and Motivators | RespVaxView | Data | Centers for Disease Control and Prevention (cdc.gov)","131":"Weekly Cumulative Percentage of Children Ages 6 Months -17 Years Who Are Up to date with COVID-19 Vaccines by Selected Demographics and by Season, United States","132":"Weekly Cumulative Percentage of Children Ages 6 Months -17 Years Who Are Up to date with COVID-19 Vaccines and Comparison Between 2023-24 and 2024-25 by Jurisdiction","133":"Weekly Parental Intent for Vaccination and Cumulative Percentage of Children 6 Months -17 Years Who are Up to date with the COVID-19 Vaccines by Season, United States","134":"Weekly Differences in Cumulative Influenza Vaccination Coverage by Selected Demographics and by Season, 2024-25 and 2024-25 Compared with 2023-24, Children 6 Months -17 Years, United States","135":"Weekly Cumulative Influenza Vaccination Coverage and Comparison Between 2023\u201324 and 2024\u201325\u00b1 by Jurisdiction, Children 6 Months\u201317 Years, United States","136":"Weekly Influenza Vaccination Status and Intent for Vaccination, Overall, by Selected Demographics, and Jurisdiction, Children 6 Months-17 Years, United States","137":"Weekly Cumulative Influenza Vaccination Coverage by Flu Season, Selected Demographics, and Race and Ethnicity Among Children 6 Months-17 Years, United States","138":"National Ambulatory Medical Care Survey (NAMCS) Linked to National Death Index (NDI) Data","139":"DQS Functional difficulties in adults age 18 and older, by selected characteristics: United States","140":"Monthly Cumulative Number and Percent of Who Received \u22651 Influenza Vaccination Doses and Comparison Between 2024-25 and Two Previous Seasons, by Jurisdiction, United States","141":"Monthly Cumulative Number and Percent of Persons Children 6 Months\u201317 Years Who Received \u22651 Influenza Vaccination Doses, by Influenza Season, Age Group, and Jurisdiction, United States","142":"Monthly Cumulative Number and Percent of Persons Who Received 1+ 2024-25 COVID-19 Vaccination Doses and Comparison between 2024-25 and 2023-24 Seasons, by Age Group and Jurisdiction, United States","143":"Monthly Cumulative Number and Percent of Persons Who Received 1+ 2024-25 COVID-19 Vaccination Doses, by Age Group, and Jurisdiction, United States","144":"NHIS\u2014Teen Restricted Use File","145":"Weekly Cumulative Estimated Number of RSV Vaccinations Administered in Retail Pharmacies and Physicians\u2019 Medical Offices, Adults 60 to 74 Years and 75 years and older, United States","146":"Level of Acute Respiratory Illness (ARI) Activity by State","147":"Preliminary 2024-2025 U.S. RSV Burden Estimates","148":"Preliminary Estimates of Cumulative RSV-associated Hospitalizations by Week for 2024-2025 season","149":"Preliminary 2024-2025 U.S. COVID-19 Burden Estimates","150":"Weekly Respiratory Syncytial Virus (RSV) Vaccination Coverage among Pregnant or Recently Pregnant Women 18-49 Years, by Race and Ethnicity","151":"Weekly Cumulative Estimated Number of COVID-19 Vaccinations Administered in Pharmacies and Physician Medical Offices, Adults 18 years and older, by Season and Age Group, United States","152":"Weekly COVID-19 Vaccination Coverage Among Pregnant Women 18-49 Years, by Race and Ethnicity","153":"Weekly Cumulative Doses (in Millions) of Influenza Vaccines Distributed by Season, United States","154":"CDT_INDIVIDUAL_BY_WEEK_LOCAL","155":"Cancer Research Citation Search","156":"HUS_Footnote_Look_Up_ASTHCH","157":"Asthma in children younger than age 18, by selected characteristics: United States.","158":"Weekly Cumulative Estimated Number of Influenza Vaccinations Administered in Pharmacies and Physician Medical Offices, Adults 18 years and older, by Flu Season and Age Group, United States","159":"Infant Protection Against Respiratory Syncytial Virus (RSV) by Maternal RSV Vaccination or Receipt of Nirsevimab, and Intent for Nirsevimab Receipt, United States","160":"Weekly Differences in Cumulative RSV Vaccination Coverage Among Adults 75 and Older and 60\u201374 Years with High-Risk Conditions Ever Vaccinated with RSV Vaccine, Overall, by Selected Demographics","161":"Weekly Cumulative RSV Vaccination Coverage and Intent, Overall, by Selected Demographics and Jurisdiction, Among Adults 75 and Older and 60-74 Years with High-Risk Conditions Ever Vaccinated, United States","162":"Preliminary Estimates of Cumulative COVID-19-associated Hospitalizations by Week for 2024-2025","163":"Weekly Differences in Cumulative COVID-19 Vaccination Coverage and Comparison Between 2024\u201325 and 2023\u201324 Among Adults 18 Years, Overall, by Selected Demographics","164":"Weekly Differences in Cumulative COVID-19 Vaccination Coverage and Comparison Between 2024\u201325 and 2023\u201324, Overall, by Jurisdiction Among Adults 18 Years","165":"Weekly Cumulative Influenza Vaccination Coverage and Comparison Between 2024\u201325 and 2023\u201324, Overall, by Jurisdiction, Among Adults 18 Years and Older","166":"Weekly Cumulative COVID-19 Vaccination Coverage and Intent, Overall, by Selected Demographics and Jurisdiction, Among Adults 18 Years and Older","167":"Weekly counts of deaths from all causes by jurisdiction,  2015-2019","168":"DQS Health care employment and wages, by selected occupations: United States","169":"Pathway to Practice (P2P) Resource Center","170":"Weekly Influenza Vaccination Coverage and Intent for Vaccination, Overall, by Selected Demographics and Jurisdiction, Among Adults 18 Years and Older","171":"Weekly Differences in Cumulative Influenza Vaccination Coverage and Comparison Between 2024-25 and 2023-24 Among Adults 18 Years, Overall, by Selected Demographics","172":"Weekly Influenza Vaccination Coverage Among Pregnant Women 18-49 Years, by Race and Ethnicity","173":"DQS Death rates for malignant neoplasms, by sex, race, Hispanic origin, and age: United States","174":"DQS Use of selected substances in the past 30 days among 12th graders, 10th graders, and 8th graders, by sex and race: United States","175":"HHS DRIVE","176":"RESP-LENS","177":"DQS Infant, neonatal, and postneonatal mortality rates, by detailed race and Hispanic origin of mother: United States","178":"DQS_Fetal, late fetal, and perinatal mortality rates, by detailed race and Hispanic origin of mother United States","179":"DQS Prescription drug use in the past 30 days, by sex, race and Hispanic origin, and age group: United States","180":"National Ambulatory Medical Care Survey, Health Center Component, 2022, Public-use file","181":"National Ambulatory Medical Care Survey, Health Center Component, Preliminary Estimates dashboard","182":"dhds_dataset","183":"dhds_dataset","184":"dhds_dataset","185":"dhds_dataset","186":"dhds_dataset","187":"dhds_dataset","188":"dhds_dataset","189":"dhds_dataset","190":"dhds_dataset","191":"dhds_dataset","192":"dhds_dataset","193":"dhds_dataset","194":"dhds_dataset","195":"dhds_dataset","196":"dhds_dataset","197":"dhds_dataset","198":"dhds_dataset","199":"dhds_dataset","200":"dhds_dataset","201":"dhds_dataset","202":"dhds_dataset","203":"dhds_dataset","204":"dhds_dataset","205":"dhds_dataset","206":"dhds_dataset","207":"dhds_dataset","208":"DQS Hypertension in adults age 20 and older, by selected characteristics: United States.","209":"NCHS Rapid Survey Systems Restricted Use File","210":"DQS Cholesterol in adults age 20 and older, by selected characteristics: United States","211":"PLACES: Place Data (GIS Friendly Format), 2023 release","212":"PLACES: ZCTA Data (GIS Friendly Format), 2023 release","213":"PLACES: Census Tract Data (GIS Friendly Format), 2023 release","214":"PLACES: County Data (GIS Friendly Format), 2023 release","215":"PLACES: Local Data for Better Health, Place Data 2023 release","216":"PLACES: Local Data for Better Health, ZCTA Data 2023 release","217":"PLACES: Local Data for Better Health, Census Tract Data 2023 release","218":"PLACES: Local Data for Better Health, County Data 2023 release","219":"NORS","220":"DQS Hospital admission, average length of stay, outpatient visits, and outpatient surgery by type of ownership and size of hospital: United States","221":"DQS Community hospital beds, by state: United States","222":"NCHS Research and Development Survey (RANDS) Round 8 Restricted File","223":"Cardiovascular Disease Death Rates, Trends, and Excess Death Rates Among US Adults (35+) by County and Age Group \u2013 2010-2020","224":"U.S. State Life Expectancy by Sex, 2021","225":"Weekly United States Hospitalization Metrics by Jurisdiction, During Mandatory Reporting Period from August 1, 2020 to April 30, 2024, and for Data Reported Voluntarily Beginning May 1, 2024, National Healthcare Safety Network (NHSN) (Historical)-ARCHIVED","226":"Weekly United States Hospitalization Metrics by Jurisdiction, During Mandatory Reporting Period from August 1, 2020 to April 30, 2024, and for Data Reported Voluntarily Beginning May 1, 2024, National Healthcare Safety Network (NHSN) - ARCHIVED","227":"National Hospital Care Survey, 2020 public-use file","228":"Weekly Rates of Laboratory-Confirmed COVID-19 Hospitalizations from the COVID-NET Surveillance System","229":"CDC.gov CleanSlate and Relaunch URL Mappings","230":"Mental Health-Related Disparities in Cigarette Smoking Among Adults","231":"Urban-Rural Related Disparities in Cigarette Smoking Among Adults","232":"Sex at Birth Related Disparities in Cigarette Smoking Among Adults","233":"Race and Ethnic Disparities in Cigarette Smoking Among Adults","234":"Income-Related Disparities in Cigarette Smoking Among Adults","235":"Employment-Related Disparities in Cigarette Smoking Among Adults","236":"Education Attained Disparities in Cigarette Smoking Among Adults","237":"Disability-Related Disparities in Cigarette Smoking Among Adults","238":"Age-Related Disparities in Cigarette Smoking Among Adults","239":"State Tobacco Related Disparities Dashboard Data","240":"Environmental Antecedents of Foodborne Illness Outbreaks","241":"COVID-19-related School Closures: USA, 2020-2022","242":"CDC Text Corpora for Learners: HTML Mirrors of MMWR, EID, and PCD","243":"CDC Text Corpora for Learners: MMWR, EID, and PCD Article Metadata","244":"Preliminary Estimates of Visits to Health Centers in the United States, January 2022-June 2024","245":"DQS NHANES Select Mean Dietary Intake Estimates","246":"DQS NHANES Select Chronic Conditions Prevalence Estimates","247":"National Hospital Care Survey 2013-2016, 2019-2021, restricted data","248":"DQS Death rates for suicide, by sex, race, Hispanic origin, and age: United States from CDC WONDER","249":"National Ambulatory Medical Care Survey, Health Center Component, 2021-2022, restricted data","250":"National Ambulatory Medical Care Survey, 2020-2021, restricted physician-only data","251":"National Ambulatory Medical Care Survey: Culturally and Linguistically Appropriate Services Supplement, 2016 Restricted-data","252":"DQS Visits to physician offices, hospital outpatient departments, and hospital emergency departments, by age, sex, and race: United States","253":"DQS Medicaid coverage among persons under age 65, by selected characteristics: United States","254":"DQS Drug overdose death rates, by drug type, sex, age, race, and Hispanic origin: United States from CDC WONDER","255":"DQS NHIS Children Summary Statistics Footnotes","256":"DQS NHIS Children Summary Statistics","257":"DQS NHIS Adult Summary Statistics Footnotes","258":"DQS NHIS Adult Summary Health Statistics","259":"DQS Estimate of Emergency Department Visits in the United States Footnotes","260":"DQS Estimate of Emergency Department Visits in the United States, 2016-2022","261":"DQS Initial injury-related visits to hospital emergency departments, by sex, age, and intent and mechanism of injury: United States","262":"Stroke Mortality Data Among US Adults (35+) by State\/Territory and County \u2013 2019-2021","263":"Provisional drug overdose death counts for specific drugs","264":"DQS Normal weight, overweight, and obesity among adults aged 20 and over, by selected characteristics: United States","265":"DQS Dentists, by state: United States.","266":"DQS Low birthweight live births, by race and Hispanic origin of mother, state, and territory: United States and U.S. dependent areas","267":"DQS Delay or nonreceipt of needed medical care, prescription drugs, or dental care during the past 12 months due to cost: United States","268":"DQS Obesity among children and adolescents aged 2\u201319 years, by selected characteristics: United States","269":"DQS Death rates for heart disease, by sex, race, Hispanic origin, and age: United States from CDC WONDER","270":"DQS Infant mortality rates, by race and Hispanic origin of mother, state, and territory: United States and U.S. dependent areas (Archived)","271":"National Hospital Ambulatory Medical Care Survey, Public-use data 1992-2022","272":"National Electronic Health Records Survey, Public-use data: 2018, 2019, 2021","273":"Heart Disease Mortality Data Among US Adults (35+) by State\/Territory and County \u2013 2019-2021","274":"DQS Health, United States Dataset Footnote Lookup","275":"Lack of Social Connection","276":"dataset_for_databricks_demo","277":"DQS NHANES Select Infectious Diseases Prevalence Estimates","278":"DQS NHANES Footnotes","279":"Weekly Cumulative RSV Vaccination Coverage, by Race and Ethnicity, Medicare Fee-For-Service Beneficiaries aged \u226565 years, United States, Data Source: Centers for Medicare & Medicaid Services Chronic Conditions Warehouse","280":"Weekly Cumulative Updated 2023-24 COVID-19 Vaccination Coverage, by Race and Ethnicity, Medicare Fee-For-Service Beneficiaries aged \u226565 years, United States, Data Source: Centers for Medicare & Medicaid Services Chronic Conditions Warehouse","281":"Monthly Cumulative Number and Percent of Adults 60 Years and Older Who Received at least one RSV Vaccination Doses by Jurisdiction, United States","282":"Monthly Cumulative Number and Percent of Children <20 Months Who Received Nirsevimab by Age Group and Jurisdiction, United States","283":"Monthly Cumulative Number and Percent of Persons Who Received 1+ updated 2023-24 COVID-19 Vaccination Doses by Age Group and Jurisdiction, United States","284":"Monthly Cumulative Number and Percent of Persons Who Received 1+ updated 2023-24 COVID-19 Vaccination Doses by Age Group and Jurisdiction, United States","285":"Monthly COVID-19 Death Rates per 100,000 Population by Age Group, Race and Ethnicity, Sex, and Region with Double Stratification","286":"DQS NHANES Select Oral Health Prevalence Estimates","287":"Monthly Cumulative Number and Percent of Persons Who Receive \u22651 Influenza Vaccination Doses and Comparison Between 2023-2024 and Two Previous Seasons, by Jurisdiction, United States","288":"Monthly Cumulative Number and Percent of Persons Who Received \u22651 Influenza Vaccination Doses, by Flu Season, Age Group, and Jurisdiction","289":"2004 National Nursing Home Survey - Restricted Resident Medications Dataset","290":"2004 National Nursing Home Survey - Restricted Current Resident Dataset","291":"2004 National Nursing Assistant Survey - Restricted Dataset","292":"National Immunization Survey Child COVID Module (NIS-CCM): COVIDVaxViews| Data | Centers for Disease Control and Prevention (cdc.gov)","293":"An aggregated dataset of serially collected influenza A virus morbidity and titer measurements from virus-infected ferrets.","294":"Influenza-related School Closures: USA, 2011-2022","295":"2004 National Nursing Home Survey - Restricted Facility Dataset","296":"Monthly Nirsevimab Receipt and Intent Among Females Aged 18-49 Years Who Have a Baby <8 Months, Are Currently Pregnant, or Are Trying to Get Pregnant, United States","297":"NSSP Emergency Department Visit Trajectories by State and Sub State Regions- COVID-19, Flu, RSV, Combined\u202f\u202f","298":"Percent Positivity of Viral Detections Among Enrolled Children in the New Vaccine Surveillance Network (NVSN), Acute Respiratory Illnesses (ARI), 2017\u2013Present","299":"Examination of SARS-CoV-2 serological test results from multiple commercial and laboratory platforms with an in-house serum panel","300":"Provisional COVID-19 death counts and rates by month, jurisdiction of residence, and demographic characteristics","301":"Weekly Respiratory Syncytial Virus (RSV) Vaccination Coverage among Pregnant Women by Race and Ethnicity","302":"Weekly Differences in Cumulative Percentage of Children Ages 6 Months -17 Years who are up to date with the updated 2023-24 COVID-19 Vaccine, by Selected Demographics","303":"Weekly Cumulative Percentage of Children Ages 6 Months -17 Years who are up to date with the updated 2023-24 COVID-19 Vaccine, by Jurisdiction","304":"Weekly Cumulative Percentage of Adults 18 Years and Older Vaccinated with the Updated 2023-24 COVID-19 Vaccine by Jurisdiction","305":"Weekly Cumulative Percentage of Adults 60 Years and Older Vaccinated with Respiratory Syncytial Virus (RSV) Vaccine by Jurisdiction","306":"NCHS Survey Data Linked to Centers for Medicare & Medicaid Services (CMS) 1999-2013 Medicare Data","307":"Pathogen Detections Among Enrolled Children in the New Vaccine Surveillance Network (NVSN), Acute Respiratory Illnesses (ARI), 12 Month Rolling Period","308":"Weekly Cumulative Estimated Number of RSV Vaccinations Administered in Pharmacies and Physician Medical Offices, Adults 60 years and older, United States","309":"Weekly Cumulative Estimated Number of Updated 2023-24 COVID-19 Vaccinations Administered in Pharmacies and Physician Medical Offices, Adults 18 years and older, United States, Data Source(s): IQVIA Pharmacy and Physician Medical Office Claims","310":"dhds_dataset","311":"National Ambulatory Medical Care Survey, Restricted data, 1973, 1975-1981, 1985, 1989-2016, 2018-2019","312":"National Ambulatory Medical Care Survey, Public-use file, 1973-2019","313":"JMK_DHDS_POC","314":"Weekly Influenza Vaccination Status and Intent for Vaccination, Overall, by Selected Demographics, and Jurisdiction, Children 6 Months - 17 Years, 2023-24, United States","315":"2023 Respiratory Virus Response - NSSP Emergency Department Visit Trajectories by State- COVID-19, Flu, RSV, Combined","316":"U.S. Chronic Disease Indicators","317":"Percent of Tests Positive for Viral Respiratory Pathogens","318":"Monthly Rates of Laboratory-Confirmed COVID-19 Hospitalizations from the COVID-NET Surveillance System","319":"Weekly Parental Intent for Vaccination and Cumulative Percentage of Children 6 Months-17 Years who are up to date with the updated 2023-24 COVID-19 Vaccine","320":"Cumulative Percentage of Children Ages 6 Months -17 Years Who Are Up to Date with the Updated 2023-24 COVID-19 Vaccine","321":"Weekly Respiratory Virus Vaccination Data, Children 6 Months-17 Years and Adults 18 Years and Older, National Immunization Survey","322":"Weekly COVID-19 Vaccination Coverage among Pregnant Women by Race and Ethnicity","323":"Weekly Cumulative Influenza Vaccination Coverage, Adults 18 and Older, United States","324":"SDOH Measures for ZCTA, ACS 2017-2021","325":"SDOH Measures for Place, ACS 2017-2021","326":"SDOH Measures for Census Tract, ACS 2017-2021","327":"SDOH Measures for County, ACS 2017-2021","328":"edav-demo-dataset-api","329":"Monthly COVID-19 Death Rates per 100,000 Population by Age Group, Race and Ethnicity, Sex, and Region","330":"NSSP Emergency Department Visits - COVID-19, Flu, RSV, Combined \u2013 by Demographic Category","331":"National Hospital Ambulatory Medical Care Survey, 1992-2021, Restricted","332":"Provisional Percent of Deaths for COVID-19, Influenza, and RSV by Select Characteristics","333":"Provisional Percent of Deaths for COVID-19, Influenza, and RSV","334":"Respiratory Virus Response (RVR) United States Hospitalization Metrics by Jurisdiction, Timeseries \u2013 ARCHIVED","335":"Outpatient Respiratory Illness Activity Map","336":"Percent Positivity of Respiratory Syncytial Virus Nucleic Acid Amplification Tests by HHS Region, National Respiratory and Enteric Virus Surveillance System","337":"Weekly United States COVID-19 Cases and Deaths among Dialysis Patients - ARCHIVED","338":"Patient Characteristics of Laboratory-Confirmed COVID-19 Hospitalizations from the COVID-NET Surveillance System","339":"NHIS Teen","340":"2023 Respiratory Virus Response - NSSP Emergency Department Visits - COVID-19, Flu, RSV, Combined","341":"SocrataDataRefresh_Test","342":"Development of an Empirically Derived Measure of Food Safety Culture in Restaurants","343":"COVID-19 Deaths Among Healthcare Personnel, by week - ARCHIVED","344":"COVID-19 Cases Among Healthcare Personnel, by week - ARCHIVED","345":"Total COVID-19 Deaths since January 1, 2020 by Age Group, Race\/Ethnicity, and Sex","346":"Weekly COVID-19 cases among persons \u22655 years old among unvaccinated and vaccinated with a BNT162b2 (Pfizer-BioNTech) primary series by age group \u2014 22 U.S. jurisdictions, January 16 to May 28, 2022","347":"v-safe COVID-19 MedDRA coded text responses","348":"National Ambulatory Medical Care Survey: Culturally and Linguistically Appropriate Services Supplement, 2016","349":"United States COVID-19 Hospitalization Metrics by Jurisdiction, Timeseries \u2013 ARCHIVED","350":"Weekly United States COVID-19 Hospitalization Metrics by Jurisdiction \u2013 ARCHIVED","351":"Community Water Fluoridation \u2013 State and County Level Statistics","352":"National Survey of Residential Care Facilities - Restricted Resident-Level Dataset","353":"National Electronic Health Records Survey, Restricted data: 2012-2015, 2017-2019, 2021","354":"National Ambulatory Medical Care Survey: Electronic Medical Records Supplement, 2008-2011, Restricted","355":"National Survey of Residential Care Facilities - Restricted Facility-Level Dataset","356":"National Hospital Discharge Survey (NHDS) 1970-2010","357":"National Hospital Discharge Survey (NHDS) Restricted Data, 1965-2010","358":"2020 Final Assisted Reproductive Technology (ART) Patient and Cycle Characteristics","359":"2020 Final Assisted Reproductive Technology (ART) Summary","360":"2020 Final Assisted Reproductive Technology (ART) Services and Profiles","361":"2020 Final Assisted Reproductive Technology (ART) Success Rates","362":"COVID-19 Vaccines Up to Date Status","363":"COVID-19 Updated Vaccines Distributed","364":"v-safe mpox","365":"We Are Moving","366":"PLACES: Local Data for Better Health, Place Data 2022 release","367":"PLACES: Local Data for Better Health, County Data 2022 release","368":"PLACES: Local Data for Better Health, Census Tract Data 2022 release","369":"PLACES: Local Data for Better Health, ZCTA Data 2022 release","370":"PLACES: County Data (GIS Friendly Format), 2022 release","371":"PLACES: Census Tract Data (GIS Friendly Format), 2022 release","372":"PLACES: ZCTA Data (GIS Friendly Format), 2022 release","373":"PLACES: Place Data (GIS Friendly Format), 2022 release","374":"Weekly United States COVID-19 Hospitalization Metrics by County (Historical) \u2013 ARCHIVED","375":"Vaccination Data Update archive","376":"Weekly United States COVID-19 Cases and Deaths by County - ARCHIVED","377":"Trends in COVID-19 Cases and Deaths in the United States, by County-level Population Factors - ARCHIVED","378":"NCHS Research and Development Survey (RANDS) Round 7 Restricted File","379":"Percent Positivity of COVID-19 Nucleic Acid Amplification Tests by HHS Region, National Respiratory and Enteric Virus Surveillance System","380":"1998-2022 Serotype Data for Invasive Pneumococcal Disease Cases by Age Group from Active Bacterial Core surveillance","381":"Weekly United States COVID-19 Hospitalization Metrics by County \u2013 ARCHIVED","382":"Water Fluoridation - Percentage of PWS population who receive fluoridated water","383":"NOHSS Adult Indicators - Adults who have visited a dentist or dental clinic in the past year","384":"Public-Use Linked Mortality Files","385":"Percent of population served by CWS that are receiving fluoridated water","386":"Adults aged 65+ who have lost six or more teeth due to tooth decay or gum disease (by Race)","387":"Adults aged 65+ who have lost all of their natural teeth due to tooth decay or gum disease (by Race)","388":"Graph of Unintended Pregnancies Among Women Having a Live Birth","389":"Graph of Tobacco Use 3 Months Before and Last 3 Months of Pregnancy","390":"Biennial Overview of Post-acute and Long-term Care in the United States: Data from the 2020 National Post-acute and Long-term Care Study","391":"Graph of Rates of Teeth Cleaning During Pregnancy","392":"Graph of Rates of Infant Sleeping on Back","393":"Provisional COVID-19 death counts and rates, by jurisdiction of residence and demographic characteristics","394":"Graph of Rates of Breastfeeding Initiation and Continuation at 1 and 2 Months","395":"Graph of Postpartum Contraception Use","396":"Graph of Maternal Prepregnancy Obesity Rates (BMI >=30)","397":"Graph of Daily Multivitamin Use Just Prior to Pregnancy","398":"Graph of Alcohol Use 3 Months Before and Last 3 Months of Pregnancy","399":"Characteristics Associated with Successful Foodborne Outbreak Investigations, NEARS 2014 - 2016","400":"Measles Case and Genetic Metadata, Operation Allies Welcome","401":"trails_lines","402":"trailheads","403":"CDC COVID-19 Cases and Deaths Ensemble Forecast Archive","404":"National Survey of Family Growth 2017-2019 Public-Use Files","405":"National Health Interview Survey","406":"BEAM Dashboard - Serotypes of concern: Burden and Trajectory","407":"BEAM Dashboard - Serotypes of concern: Illnesses and Outbreaks","408":"Household Pulse Survey (HPS): COVID-19 Vaccination among People with Disabilities","409":"Provisional COVID-19 death counts, rates, and percent of total deaths, by jurisdiction of residence","410":"National Community Based Survey of Supports for Healthy Eating and Active Living  (CBS HEAL)","411":"VSRR Provisional Maternal Death Counts and Rates","412":"NCHS Research and Development Survey (RANDS) Round 6 Restricted File","413":"NCHS Research and Development Survey (RANDS) Round 5 Restricted File","414":"Daily County-Level PM2.5 Concentrations, 2001-2019","415":"Daily County-Level Ozone Concentrations, 2001-2019","416":"Daily Census Tract-Level PM2.5 Concentrations, 2016 - 2020","417":"Daily Census Tract-Level Ozone Concentrations, 2016 - 2020","418":"NCHS Rapid Surveys System","419":"NHIS Adult 3-Year Summary Health Statistics","420":"county-level ASD prevalence estimates","421":"Restricted Use National Survey of Family Growth (NSFG)","422":"National Health and Nutrition Examination Survey (NHANES) Genetic Restricted Data","423":"NHANES National Youth Fitness Survey (NNYFS) Restricted Data","424":"National Health and Nutrition Examination Survey (NHANES) Restricted Data: 1999 to Present","425":"National Health and Nutrition Examination Survey (NHANES) Restricted Data: Prior to 1999","426":"NCHS - All-County Fetal Death File with Exact Date of Delivery","427":"NCHS - All-County Linked Births\/Infant Deaths File with Exact Dates of Birth and Death","428":"National Hospital Care Survey (NHCS) linked to Department of Veterans Affairs Administrative Data Files","429":"National Hospital Care Survey (NHCS) linked to Centers for Medicare & Medicaid (CMS) Medicaid Data","430":"NCHS Survey Data Linked to Department of Veterans Affairs Administrative Data Files","431":"NCHS Survey Data Linked to Centers for Medicare & Medicaid Services (CMS) Medicaid Enrollment and Claims Files","432":"COVID-19 Weekly Cases and Deaths by Age, Race\/Ethnicity, and Sex - ARCHIVED","433":"Rates of Laboratory-Confirmed RSV, COVID-19, and Flu Hospitalizations from the RESP-NET Surveillance Systems","434":"Differences in Cumulative Influenza Vaccination Coverage by Selected Demographics, Adults 18 Year and Older, NIS Adult COVID Module","435":"Cumulative Influenza Vaccination Coverage and Comparison, Adults 18 Years and Older, US, National Immunization Survey-Adult COVID Module","436":"Cumulative Influenza Vaccination Coverage by Age Group, Race\/Ethnicity, Urbanicity and Jurisdiction, NIS-ACM, Adults 18 Years and Older - NIS ACM","437":"BEAM Dashboard - Isolates by HHS Region","438":"v-safe COVID-19","439":"BEAM Dashboard \u2013 Top 30 Most Common Serotypes","440":"BEAM Dashboard - Report Data","441":"Rates of COVID-19 Cases or Deaths by Age Group and Updated (Bivalent) Booster Status","442":"2022\u20132023 Nationwide Blood Donor Seroprevalence Survey Combined Infection- and Vaccination-Induced Seroprevalence Estimates","443":"Dataset Update","444":"Weekly Rates of Laboratory-Confirmed RSV Hospitalizations from the RSV-NET Surveillance System","445":"AH COVID-19 Death Counts by County and Week, 2020-present","446":"Outbreak Data - Restaurant Grading","447":"Survey Data - Restaurant Grading","448":"PLACES and 500 Cities: Data Dictionary","449":"Weekly COVID-19 County Level of Community Transmission Historical Changes - ARCHIVED","450":"Weekly COVID-19 County Level of Community Transmission as Originally Posted - ARCHIVED","451":"Weekly United States COVID-19 Cases and Deaths by State - ARCHIVED","452":"Upcoming Reporting Cadence Change","453":"PLACES: Place Data (GIS Friendly Format), 2021 release","454":"PLACES: Local Data for Better Health, Place Data 2021 release","455":"PLACES: Local Data for Better Health, ZCTA Data 2021 release","456":"PLACES: County Data (GIS Friendly Format), 2021 release","457":"PLACES: Census Tract Data (GIS Friendly Format), 2021 release","458":"PLACES: Local Data for Better Health, Census Tract Data 2021 release","459":"PLACES: ZCTA Data (GIS Friendly Format), 2021 release","460":"PLACES: Local Data for Better Health, County Data 2021 release","461":"Weekly Cumulative Estimated Number of Influenza Vaccinations Administered in Pharmacies and Physician Medical Offices, Adults 18 years and older, United States (ARCHIVED)","462":"Cumulative Influenza Vaccination Coverage by Race\/Ethnicity and Age Group, NIS-ACM (Archived)","463":"Cumulative Influenza Vaccination Coverage Differences by Race\/Ethnicity, Children 6 months through 17 years, United States","464":"Weekly Cumulative Influenza Vaccination Coverage, Children 6 months through 17 years, United States","465":"Weekly Cumulative Influenza Vaccine Doses Distributed in the United States","466":"AH Provisional COVID-19 Deaths by HHS Region, Race, Age 65plus","467":"U.S. State Life Expectancy by Sex, 2020","468":"AH Provisional COVID-19 Deaths by Week and Age","469":"NHANES Select Infectious Diseases Prevalence Estimates","470":"NHANES Select Oral Health Prevalence Estimates","471":"NHANES Select Mean Dietary Intake Estimates","472":"NHANES Select Chronic Conditions Prevalence Estimates","473":"COVID-19 Primary Series Completion, Booster Dose Eligibility, and Booster Dose Receipt by Age, United States\u00a0","474":"Respiratory Syncytial Virus Laboratory Data (NREVSS)","475":"National Hospital Care Survey (NHCS) linked to Department of Housing and Urban Development (HUD) Administrative Housing Data","476":"National Hospital Care Survey (NHCS) linked to Centers for Medicare & Medicaid (CMS) 2014-2018 Medicare Data","477":"National Hospital Care Survey (NHCS) Linked to National Death Index (NDI) Data","478":"Post-COVID Conditions","479":"Rates of COVID-19 Cases or Deaths by Age Group and Vaccination Status and Second Booster Dose","480":"NCHS Survey Data Linked to United States Renal Data System (USRDS) End-Stage Renal Disease Files","481":"NCHS Survey Data Linked to the Department of Housing and Urban Development (HUD) Housing Assistance Program Files","482":"NCHS Survey Data Linked to Centers for Medicare & Medicaid Services (CMS) MAX Data","483":"NCHS Survey Data Linked to Centers for Medicare & Medicaid Services (CMS) Medicare Data Files","484":"Vaccination Data Update","485":"NCHS Research and Development Survey (RANDS) Round 2 during COVID-19 probability sampled Restricted File","486":"NCHS Research and Development Survey (RANDS) Round 1 during COVID-19 non-probability sampled Restricted File","487":"NCHS Research and Development Survey (RANDS) Round 1 during COVID-19 probability sampled Restricted File","488":"NCHS Research and Development Survey (RANDS) Round 4 Restricted File","489":"NCHS Research and Development Survey (RANDS) Round 3 Restricted File","490":"NCHS Research and Development Survey (RANDS) Round 2 Restricted File","491":"NCHS Research and Development Survey (RANDS) Round 1 Restricted File","492":"National Post-acute and Long-term Care Study: Residential Care Community Restricted Dataset","493":"National Post-acute and Long-term Care Study: Adult Day Service Provider Restricted Dataset","494":"Health Service Area Population Greater Than 2Million","495":"NCHS Survey Data Linked to National Death Index (NDI) Mortality Files","496":"NCHS Research and Development Survey (RANDS) Round 3 during COVID-19 Restricted File","497":"NCHS Research and Development Survey (RANDS) Round 2 during COVID-19 non-probability sampled Restricted File","498":"NCHS - All-County Natality File with Exact Date of Birth","499":"Estimates of Emergency Department Visits in the United States from 2016-2022","500":"Drug-Involved Mortality (DIM) data available through the Research Data Center (RDC)","501":"Restricted mortality data from the National Vital Statistics System","502":"COVID-19 Vaccination Age and Sex Trends in the United States, National and Jurisdictional","503":"Monthly Rates of Laboratory-Confirmed RSV Hospitalizations from the RSV-NET Surveillance System","504":"United States COVID-19 County Level Data Sources - ARCHIVED","505":"NWSS Public SARS-CoV-2 Concentration in Wastewater Data","506":"testing_cte_aspost","507":"Drug Use Data from Selected Hospitals","508":"AH Provisional COVID-19 Deaths by HHS Region, Race, and Age, 2015 to date","509":"United States COVID-19 Community Levels by County","510":"Population Group Estimates used in the Healthy People 2020 Overview of Health Disparities","511":"State-Level Restrictions on Vaccine Mandate \u2013 Currently in Effect","512":"State-Level Restrictions on Vaccine Mandates \u2013 All","513":"State-Level Vaccine Mandates - Currently in Effect","514":"State-Level Vaccine Mandates - All","515":"Rates and Trends in Heart Disease and Stroke Mortality Among US Adults (35+) by County, Age Group, Race\/Ethnicity, and Sex \u2013 2000-2019","516":"Rates and Trends in Hypertension-related Cardiovascular Disease Mortality Among US Adults (35+) by County, Age Group, Race\/Ethnicity, and Sex \u2013 2000-2019","517":"U.S. State Life Expectancy by Sex, 2019","518":"COVID-19 Booster Dose Eligibility in the United States","519":"Healthy People 2020 Foundation Health Measures","520":"Cumulative Influenza Vaccination Coverage by Race\/Ethnicity and Age Group, NIS-ACM","521":"NNDSS - TABLE 1PP. Viral hemorrhagic fevers, Sabia virus to Zika virus disease, non-congenital","522":"NNDSS - TABLE 1OO. Viral hemorrhagic fevers, Lujo virus to Viral hemorrhagic fevers, Marburg virus","523":"NNDSS - TABLE 1NN. Viral hemorrhagic fevers, Guanarito virus to Viral hemorrhagic fevers, Lassa virus","524":"NNDSS - TABLE 1MM. Viral hemorrhagic fevers, Chapare virus to Ebola virus","525":"NNDSS - TABLE 1LL. Vibriosis, Confirmed to Vibriosis, Probable","526":"NNDSS - TABLE 1KK. Vancomycin-intermediate Staphylococcus aureus to Varicella morbidity","527":"NNDSS - TABLE 1JJ. Tuberculosis to Tularemia","528":"NNDSS - TABLE 1II. Tetanus to Trichinellosis","529":"NNDSS - TABLE 1HH. Syphilis, Congenital to Syphilis, Primary and Secondary","530":"NNDSS - TABLE 1GG. Smallpox to Streptococcal toxic shock syndrome","531":"NNDSS - TABLE 1FF. Severe acute respiratory syndrome-associated coronavirus disease to Shigellosis","532":"NNDSS - TABLE 1EE. Salmonella Paratyphi infection to Salmonellosis (excluding Salmonella Typhi infection and Salmonella Paratyphi infection)","533":"NNDSS - TABLE 1DD. Rubella to Rubella, congenital syndrome","534":"NNDSS - TABLE 1CC. Rabies, Animal to Rabies, Human","535":"NNDSS - TABLE 1BB. Q fever, Total to Q fever, Chronic","536":"NNDSS - TABLE 1AA. Poliovirus infection, nonparalytic to Psittacosis","537":"NNDSS - TABLE 1Z. Pertussis to Poliomyelitis, paralytic","538":"NNDSS - TABLE 1Y. Mumps to Novel influenza A virus infections","539":"NNDSS - TABLE 1X. Meningococcal disease, Other serogroups to Meningococcal disease, Unknown serogroup","540":"NNDSS - TABLE 1W. Meningococcal disease, All serogroups to Meningococcal disease, Serogroup B","541":"NNDSS - TABLE 1V. Malaria to Measles, Indigenous","542":"NNDSS - TABLE 1U. Leptospirosis to Listeriosis, Probable","543":"NNDSS - TABLE 1T. Invasive pneumococcal disease, Age<5 years, Confirmed to Legionellosis","544":"NNDSS - TABLE 1S. Invasive pneumococcal disease, all ages, Confirmed to Invasive pneumococcal disease, all ages, Probable","545":"NNDSS - TABLE 1R. Hepatitis C, perinatal infection to Influenza-associated pediatric mortality","546":"NNDSS - TABLE 1Q. Hepatitis B, perinatal infection to Hepatitis C, acute, Probable","547":"NNDSS - TABLE 1P. Hemolytic uremic syndrome post-diarrheal to Hepatitis B, acute","548":"NNDSS - TABLE 1O. Hansen's disease to Hantavirus pulmonary syndrome","549":"NNDSS - TABLE 1N. Haemophilus influenzae, invasive disease, Age <5 years, Non-b serotype to Unknown serotype","550":"NNDSS - TABLE 1M. Gonorrhea to Haemophilus influenzae, invasive disease, Age <5 years, Serotype b","551":"NNDSS - TABLE 1L. Ehrlichiosis and Anaplasmosis, Ehrlichia ewingii infection to Giardiasis","552":"NNDSS - TABLE 1K. Ehrlichiosis and Anaplasmosis, Anaplasma phagocytophilum infection to Ehrlichia chaffeensis infection","553":"NNDSS - TABLE 1J. Dengue virus infections, Dengue to Severe dengue","554":"NNDSS - Table 1I. Cryptosporidiosis to Cyclosporiasis","555":"NNDSS - Table 1H. Cholera to Coccidioidomycosis","556":"NNDSS - Table 1G. Carbapenemase-producing carbapenem-resistant Enterobacteriaceae to Chlamydia trachomatis infection","557":"NNDSS - Table 1F. Brucellosis to Candida auris, clinical","558":"NNDSS - Table 1E. Botulism, Foodborne to Botulism, Other (wound & unspecified)","559":"NNDSS - Table 1D. Arboviral diseases, Western equine encephalitis virus disease to Babesiosis","560":"NNDSS - Table 1C. Arboviral diseases, St. Louis encephalitis virus disease to West Nile virus disease","561":"NNDSS - Table 1B. Arboviral diseases, Jamestown Canyon virus disease to Powassan virus disease","562":"NNDSS - TABLE 1A. Anthrax to Arboviral diseases, Eastern equine encephalitis virus disease","563":"Rates of COVID-19 Cases or Deaths by Age Group and Vaccination Status and Booster Dose","564":"Healthy People 2020 Overview of Health Disparities","565":"Weekly Cumulative Influenza Vaccination Coverage Comparison between Current and Previous Season, Children 6 Months through 17 Years, United States","566":"NWSS Public SARS-CoV-2 Wastewater Metric Data","567":"National Immunization Survey Child COVID Module (NIS-CCM): COVIDVaxViews| Data | Centers for Disease Control and Prevention (cdc.gov)-Archived","568":"Data Update Notice","569":"American Rescue Plan (ARP) Rural Payments","570":"NHIS Child Summary Health Statistics","571":"NHIS Adult Summary Health Statistics","572":"National Immunization Survey Child COVID Module (NIS-CCM): Vaccination Status and Intent by Demographics | Data | Centers for Disease Control and Prevention (cdc.gov)","573":"Archive: COVID-19 Vaccination Demographic Trends by Report Date, National","574":"Prolonged Unplanned School Closures: USA, 2011-2019","575":"Vaccines.gov: Flu vaccinating provider locations","576":"COVID-19 Coverage Assistance Fund: Claims Reimbursement to Health Care Providers and Facilities for Services to the Underinsured","577":"AH Provisional COVID-19 Death Counts by Week, Race, and Age, United States 2020-2023","578":"Rates of COVID-19 Cases or Deaths by Age Group and Vaccination Status","579":"Physician Experiences Related to COVID-19 from the National Ambulatory Medical Care Survey","580":"Archive: COVID-19 LTC Program Vaccinations and Trends in the United States, Jurisdiction","581":"AH Provisional COVID-19 Deaths by Age, United States, Week 40 2020 through Week 39 2021","582":"AH Provisional COVID-19 Death Counts by Quarter and County","583":"VSRR Provisional County-Level Drug Overdose Death Counts","584":"PLACES: ZCTA Data (GIS Friendly Format), 2020 release","585":"PLACES: Local Data for Better Health, Place Data 2020 release","586":"PLACES: Local Data for Better Health, County Data 2020 release","587":"PLACES: Place Data (GIS Friendly Format), 2020 release","588":"PLACES: County Data (GIS Friendly Format), 2020 release","589":"PLACES: Census Tract Data (GIS Friendly Format), 2020 release","590":"PLACES: Local Data for Better Health, Census Tract Data 2020 release","591":"PLACES: Local Data for Better Health, ZCTA Data 2020 release","592":"2020-2021 Nationwide Blood Donor Seroprevalence Survey Combined Infection- and Vaccination-Induced Seroprevalence Estimates","593":"2020-2021 Nationwide Blood Donor Seroprevalence Survey Infection-Induced Seroprevalence Estimates","594":"AH Provisional COVID-19 Deaths by HHS Region, Race, and Age, 2015-2021","595":"Healthy People 2020 Final Progress by Population Group Chart and Table","596":"U.S. State and Territorial Orders Closing and Reopening Bars Issued from March 11, 2020 through May 31, 2021 by County by Day","597":"U.S. State and Territorial Orders Closing and Reopening Restaurants Issued from March 11, 2020 through May 31, 2021 by County by Day","598":"U.S. State and Territorial Stay-At-Home Orders: March 15, 2020 \u2013 May 31, 2021 by County by Day","599":"U.S. State and Territorial Gathering Bans: March 11, 2020-May 31, 2021 by County by Day","600":"U.S. State and Territorial Public Mask Mandates From April 10, 2020 through July 20, 2021 by County by Day","601":"Cumulative Influenza Vaccination Coverage and Intent for Vaccination Among Adults 18 Years and Older by Age, Race\/Ethnicity, and COVID-19 Vaccination and Intent, United States; IPSOS Knowledge Panel and NORC AmeriSpeak Omnibus Surveys.","602":"AH Provisional COVID-19 Deaths by HHS Region, Race, and Age Group, 2020-2021","603":"Provisional Drug Overdose Deaths by Urban\/Rural Classification Scheme for 12 month-ending December 2018-December 2020","604":"United States COVID-19 County Level of Community Transmission Historical Changes - ARCHIVED","605":"United States COVID-19 County Level of Community Transmission as Originally Posted - ARCHIVED","606":"Household Pulse Survey (HPS): COVID-19 Vaccination among People with Disabilities","607":"National Immunization Survey Adult COVID Module (NIS-ACM): Trends in Behavioral Indicators Among Unvaccinated People","608":"National Immunization Survey Adult COVID Module (NIS-ACM): Trends in Vaccination Status and Intent","609":"NNDSS Weekly Data","610":"National Immunization Survey Adult COVID Module (NIS-ACM): Vaccination Status and Intent by Demographics","611":"Long-term Care and COVID-19","612":"NHIS Interactive Biannual Early Release Estimates","613":"Archive: COVID-19 Vaccination and Case Trends by Age Group, United States","614":"NHIS Interactive Quarterly Early Release Estimates","615":"AH Provisional Cancer Death Counts by Month and Year, 2020-2021","616":"Initial injury-related visits to hospital emergency departments, by sex, age, and intent and mechanism of injury: United States","617":"Delay or nonreceipt of needed medical care, prescription drugs, or dental care during the past 12 months due to cost: United States","618":"Visits to physician offices, hospital outpatient departments, and hospital emergency departments, by age, sex, and race: United States","619":"Provisional COVID-19 Deaths by Week and County Social Vulnerability Index","620":"HAICViz - MuGSI","621":"HAICViz - iSA","622":"HAICViz - CDI","623":"HAICViz - Candidemia","624":"Botswana Combination Prevention Project (BCPP) - Public Release Data","625":"COVID-19 Vaccination Demographics in the United States,National","626":"COVID-19 Vaccinations in the United States,Jurisdiction","627":"COVID-19 Vaccinations in the United States,County","628":"COVID-19 Vaccination Trends in the United States,National and Jurisdictional","629":"SARS-CoV-2 Variant Proportions","630":"AH Provisional COVID-19 Deaths by Week, Sex, and Race and Hispanic Origin","631":"Active Bacterial Core surveillance (ABCs) Streptococcus pneumoniae","632":"Active Bacterial Core surveillance (ABCs) Neisseria meningitidis","633":"Active Bacterial Core surveillance (ABCs) Haemophilus influenzae","634":"Active Bacterial Core surveillance (ABCs) Group B Streptococcus","635":"Active Bacterial Core surveillance (ABCs) Group A Streptococcus","636":"AH Quarterly Excess Deaths by State, Sex, Age, and Race","637":"AH Provisional COVID-19 Deaths by Week and Age","638":"Medicaid coverage among persons under age 65, by selected characteristics: United States","639":"Obesity among children and adolescents aged 2\u201319 years, by selected characteristics: United States","640":"Normal weight, overweight, and obesity among adults aged 20 and over, by selected characteristics: United States","641":"Health conditions among children under age 18, by selected characteristics: United States","642":"Death rates for suicide, by sex, race, Hispanic origin, and age: United States","643":"Drug overdose death rates, by drug type, sex, age, race, and Hispanic origin: United States","644":"Infant, neonatal, postneonatal, fetal, and perinatal mortality rates, by detailed race and Hispanic origin of mother: United States","645":"Influenza Vaccination Coverage for All Ages (6+ Months)","646":"Vaccination Coverage among Health Care Personnel","647":"Vaccination Coverage among Nursing Home Residents","648":"Vaccination Coverage among Pregnant Women","649":"Vaccination Coverage among Adults (18+ Years)","650":"Vaccination Coverage among Adolescents (13-17 Years)","651":"Vaccination Coverage and Exemptions among Kindergartners","652":"Vaccination Coverage among Young Children (0-35 Months)","653":"AH Provisional COVID-19 Deaths by Quarter, County and Age for 2020","654":"AH Provisional COVID-19 Deaths by County and Age for 2020","655":"Vaccines.gov: COVID-19 vaccinating provider locations","656":"Telemedicine Use in the Last 4 Weeks","657":"AH Provisional COVID-19 Deaths and Contributing Conditions by Sex, Race and Hispanic Origin, and Age, 2020","658":"Fully Vaccinated Adults","659":"Vaccine Hesitancy for COVID-19: Public Use Microdata Areas (PUMAs)","660":"Ability to handle a COVID-19 outbreak (CVAC)","661":"COVID-19 County Hesitancy","662":"Social Vulnerability Index","663":"Vaccine Hesitancy for COVID-19","664":"Vaccine Hesitancy for COVID-19: County and local estimates","665":"U.S. State Life Expectancy by Sex, 2018","666":"HHS Unaccompanied Children Program","667":"COVID-19 State, Tribal, Local, and Territorial Funding","668":"AH Deaths by Year, Sex, and Age for 2015-2020","669":"AH Deaths by Week, Sex, and Age for 2018-2020","670":"Provisional COVID-19 Deaths by Week and Urbanicity","671":"AH Provisional COVID-19 Deaths by Hospital Referral Region","672":"AH County of Residence COVID-19 Deaths Counts, 2020 Provisional","673":"AH Provisional COVID-19 Deaths Counts by Health Service Area","674":"Efforts to sustain education and subsidized meal programs during COVID-19-related school closures, United States, March-June 2020","675":"COVID-19-associated school closures, United States, February 18\u2013June 30, 2020","676":"Early Model-based Provisional Estimates of Drug Overdose, Suicide, and Transportation-related Deaths","677":"National Weekly Janssen Allocations","678":"COVID-19 Vaccine Distribution Allocations by Jurisdiction - Janssen","679":"NNDSS - TABLE 1N. Haemophilus influenzae, invasive disease, Age <5 years, Non-b serotype to Unknown serotype","680":"NNDSS - TABLE 1N. Haemophilus influenzae, invasive disease, Age <5 years, Non-b serotype to Unknown serotype","681":"AH Deaths by Educational Attainment, 2019-2020","682":"State Pfizer Allocation Totals","683":"National Weekly Pfizer Allocations","684":"State Moderna Allocation Totals","685":"National Weekly Moderna Allocations","686":"U.S. State and Territorial Orders Closing and Reopening Restaurants Issued from March 11, 2020 through August 15, 2021 by County by Day","687":"U.S. State and Territorial Orders Closing and Reopening Bars Issued from March 11, 2020 through August 15, 2021 by County by Day","688":"AH Monthly Provisional Counts of Deaths for Select Causes of Death by Age, and Race and Hispanic Origin","689":"Provisional COVID-19 Deaths by HHS Region, Race, and Age","690":"Monthly Provisional Counts of Deaths by Select Causes, 2020-2023","691":"Monthly Counts of Deaths by Select Causes, 2014-2019","692":"AH Provisional COVID-19 Deaths by Educational Attainment, Race, Sex, and Age","693":"COVID-19 Case Surveillance Public Use Data with Geography","694":"AH Provisional COVID-19 Deaths by Race and Educational Attainment","695":"AH Provisional COVID-19 Deaths By Race, Age, and Sex from 3\/1\/2020 to 7\/31\/2020","696":"Weekly Cumulative Influenza Vaccination Coverage, by Flu Season and Race\/Ethnicity, Medicare Fee-For-Service Beneficiaries aged \u226565 years, United States","697":"Cumulative Influenza Vaccination Coverage, Adults 18 years and older, by Age Group and Race\/Ethnicity, United States","698":"Healthy People 2020 Final Progress Table","699":"Provider Relief Fund by State","700":"NNDSS - TABLE 1PP. Yellow fever to Zika virus disease, non-congenital","701":"NNDSS - TABLE 1OO. Viral hemorrhagic fevers, Machupo virus to Viral hemorrhagic fevers, Sabia virus","702":"NNDSS - TABLE 1NN. Viral hemorrhagic fevers, Junin virus to Viral hemorrhagic fevers, Lujo virus","703":"NNDSS - TABLE 1MM. Viral hemorrhagic fevers, Crimean-Congo hemorrhagic fever virus to Guanarito virus","704":"NNDSS - TABLE 1LL. Vibriosis, Confirmed to Vibriosis, Probable","705":"NNDSS - TABLE 1KK. Vancomycin-intermediate Staphylococcus aureus to Varicella morbidity","706":"NNDSS - TABLE 1JJ. Tuberculosis to Tularemia","707":"NNDSS - TABLE 1II. Tetanus to Trichinellosis","708":"NNDSS - TABLE 1HH. Syphilis, Congenital to Syphilis, Primary and Secondary","709":"NNDSS - TABLE 1GG. Smallpox to Streptococcal toxic shock syndrome","710":"NNDSS - TABLE 1FF. Severe acute respiratory syndrome-associated coronavirus disease to Shigellosis","711":"NNDSS - TABLE 1EE. Salmonella Paratyphi infection to Salmonellosis (excluding Salmonella Typhi infection and Salmonella Paratyphi infection)","712":"NNDSS - TABLE 1DD. Rubella to Rubella, congenital syndrome","713":"NNDSS - TABLE 1CC. Rabies, Animal to Rabies, Human","714":"NNDSS - TABLE 1BB. Q fever, Total to Q fever, Chronic","715":"NNDSS - TABLE 1AA. Poliovirus infection, nonparalytic to Psittacosis","716":"NNDSS - TABLE 1Z. Pertussis to Poliomyelitis, paralytic","717":"NNDSS - TABLE 1Y. Mumps to Novel influenza A virus infections","718":"NNDSS - TABLE 1X. Meningococcal disease, Other serogroups to Meningococcal disease, Unknown serogroup","719":"NNDSS - TABLE 1W. Meningococcal disease, All serogroups to Meningococcal disease, Serogroup B","720":"NNDSS - TABLE 1V. Malaria to Measles, Indigenous","721":"NNDSS - TABLE 1U. Leptospirosis to Listeriosis, Probable","722":"NNDSS - TABLE 1T. Invasive pneumococcal disease, Age<5 years, Confirmed to Legionellosis","723":"NNDSS - TABLE 1S. Invasive pneumococcal disease, all ages, Confirmed to Invasive pneumococcal disease, all ages, Probable","724":"NNDSS - TABLE 1R. Hepatitis C, perinatal infection to Influenza-associated pediatric mortality","725":"NNDSS - TABLE 1Q. Hepatitis B, perinatal infection to Hepatitis C, acute, Probable","726":"NNDSS - TABLE 1P. Hemolytic uremic syndrome post-diarrheal to Hepatitis B, acute","727":"NNDSS - TABLE 1O. Hansen's disease to Hantavirus pulmonary syndrome","728":"NNDSS - TABLE 1M. Gonorrhea to Haemophilus influenzae, invasive disease, Age <5 years, Serotype b","729":"Weekly Cumulative Estimated Number of Influenza Vaccinations Administered in Pharmacies and Physician Medical Offices, Adults 18 years and older, United States","730":"Weekly Cumulative Influenza Vaccination Coverage, Children 6 months through 17 years, United States","731":"Weekly Cumulative Doses (in Millions) of Influenza Vaccine Distributed by Flu Season in the United States","732":"NNDSS - TABLE 1L. Ehrlichiosis and Anaplasmosis, Ehrlichia ewingii infection to Giardiasis","733":"NNDSS - TABLE 1K. Ehrlichiosis and Anaplasmosis, Anaplasma phagocytophilum infection to Ehrlichia chaffeensis infection","734":"NNDSS - TABLE 1J. Dengue virus infections, Dengue to Severe dengue","735":"NNDSS - Table 1I. Cryptosporidiosis to Cyclosporiasis","736":"NNDSS - Table 1H. Cholera to Coccidioidomycosis","737":"NNDSS - Table 1G. Carbapenemase-producing carbapenem-resistant Enterobacteriaceae to Chlamydia trachomatis infection","738":"NNDSS - Table 1F. Brucellosis to Candida auris, clinical","739":"NNDSS - Table 1E. Botulism, Foodborne to Botulism, Other (wound & unspecified)","740":"NNDSS - Table 1D. Arboviral diseases, Western equine encephalitis virus disease to Babesiosis","741":"NNDSS - Table 1C. Arboviral diseases, St. Louis encephalitis virus disease to West Nile virus disease","742":"NNDSS - Table 1B. Arboviral diseases, Jamestown Canyon virus disease to Powassan virus disease","743":"NNDSS - TABLE 1A. Anthrax to Arboviral diseases, Eastern equine encephalitis virus disease","744":"COVID-19 Vaccine Distribution Allocations by Jurisdiction - Moderna","745":"COVID-19 Hospital Data from the National Hospital Care Survey","746":"COVID-19 Vaccine Distribution Allocations by Jurisdiction - Pfizer","747":"Provider Relief Fund COVID-19 Nursing Home Quality Incentive Program","748":"COVID-19 Case Surveillance Restricted Access Detailed Data","749":"AH Excess Deaths by Sex, Age, and Race and Hispanic Origin","750":"Health, United States","751":"Prevalence of Selected Measures Among Adults Aged 20 and Over: United States, 1999-2000 through 2017-2018","752":"Nationwide Commercial Laboratory Seroprevalence Survey","753":"AH Provisional Diabetes Death Counts for 2020","754":"PLACES: ZCTA Data (GIS Friendly Format), 2024 release","755":"PLACES: Place Data (GIS Friendly Format), 2024 release","756":"PLACES: Local Data for Better Health, Census Tract Data 2024 release","757":"PLACES: Census Tract Data (GIS Friendly Format), 2024 release","758":"PLACES: Local Data for Better Health, ZCTA Data 2024 release","759":"PLACES: Local Data for Better Health, Place Data 2024 release","760":"U.S. State and Territorial Public Mask Mandates From April 8, 2020 through August 15, 2021 by State by Day","761":"AH Provisional COVID-19 Deaths by Week, Place of Death, and Age","762":"AH Sickle Cell Disease Provisional Death Counts 2019-2021","763":"PLACES: Local Data for Better Health, County Data 2024 release","764":"Provisional Death Counts for Influenza, Pneumonia, and COVID-19","765":"AH County of Occurrence COVID-19 Death Counts, 2020 Provisional","766":"Mental Health Care in the Last 4 Weeks","767":"U.S. State and Territorial Stay-At-Home Orders: March 15, 2020 \u2013 August 15, 2021 by County by Day","768":"AH Monthly COVID-19 Deaths, by Census Region, Age, Place, and Race and Hispanic Origin, 2020 Provisional","769":"Reduced Access to Care During COVID-19","770":"Access and Use of Telemedicine During COVID-19","771":"Loss of Work Due to Illness from COVID-19","772":"PLACES: County Data (GIS Friendly Format), 2024 release","773":"AH Monthly Provisional COVID-19 Deaths, by Census Region, Age, and Race and Hispanic Origin","774":"AH Monthly Provisional Counts of Deaths for Select Causes of Death by Sex, Age, and Race and Hispanic Origin","775":"AH Monthly Provisional Counts of Deaths by Age Group and HHS region for Select Causes of Death, 2019-2021","776":"Provisional COVID-19 Deaths by Place of Death and Age","777":"U.S. State and Territorial Public Mask Mandates From April 10, 2020 through August 15, 2021 by County by Day","778":"Provisional COVID-19 Death Counts by Age in Years, 2020-2023","779":"Deaths by Race and Hispanic Origin, Ages 0-18 Years","780":"Deaths by Sex, Ages 0-18 years","781":"Provisional COVID-19 Deaths: Focus on Ages 0-18 Years","782":"AH Cumulative Provisional Death Counts by Sex, Race, and Age from 1\/1\/2020 to 7\/4\/2020","783":"Distribution of COVID-19 Deaths and Populations, by Jurisdiction, Age, and Race and Hispanic Origin","784":"Number of Reported Malaria Cases by County\u2014 United States, 2017","785":"Number of Reported Malaria Cases by County\u2014 United States, 2016","786":"Weekly Counts of Deaths by Jurisdiction, and Race and Hispanic Origin","787":"AH Cumulative Provisional COVID-19 Death Counts by Place of Death and Age Group from 2\/1\/2020 to 7\/18\/2020","788":"AH Cumulative Provisional COVID-19 Deaths by Sex, Race, and Age from 1\/1\/2020 to 7\/28\/2020","789":"U.S. State and Territorial Gathering Bans: March 11, 2020-August 15, 2021 by County by Day","790":"autism prevalence studies","791":"Provisional COVID-19 Deaths by County, and Race and Hispanic Origin","792":"Claims Reimbursement to Health Care Providers and Facilities for Testing, Treatment, and Vaccine Administration  of the Uninsured","793":"Weekly Counts of Death by Jurisdiction and Select Causes of Death","794":"Weekly Counts of Deaths by Jurisdiction and Age","795":"Provider Relief Fund & Accelerated and Advance Payments","796":"Indicators of Reduced Access to Care Due to the Coronavirus Pandemic During Last 4 Weeks","797":"Indicators of Health Insurance Coverage at the Time of Interview","798":"Indicators of Anxiety or Depression Based on Reported Frequency of Symptoms During Last 7 Days","799":"COVID-19 Case Surveillance Public Use Data","800":"Provisional COVID-19 Deaths by Week, Sex, and Age","801":"U.S. State, Territorial, and County Stay-At-Home Orders: March 15-May 5 by County by Day","802":"Conditions Contributing to COVID-19 Deaths, by State and Age, Provisional 2020-2023","803":"Provisional COVID-19 Deaths by Race and Hispanic Origin, and Age","804":"Provider Relief Fund COVID-19 High-Impact Payments","805":"HHS Provider Relief Fund","806":"Provisional COVID-19 Deaths by Sex and Age","807":"Provisional COVID-19 Deaths by Place of Death and State","808":"Provisional COVID-19 Death Counts by Week Ending Date and State","809":"Excess Deaths Associated with COVID-19","810":"Weekly Provisional Counts of Deaths by State and Select Causes, 2020-2023","811":"Weekly Counts of Deaths by State and Select Causes, 2014-2019","812":"Provisional COVID-19 Death Counts in the United States by County","813":"Provisional COVID-19 Deaths: Distribution of Deaths by Race and Hispanic Origin","814":"National Artesunate for Severe Malaria Program Microscopy Data- April to December 2019","815":"National Artesunate for Severe Malaria Program Follow-On Antimalarial Dosing Data- April to December 2019","816":"National Artesunate for Severe Malaria Program Artesunate Dosing Data- April to December 2019","817":"National Artesunate for Severe Malaria Program Case Report Data- April to December 2019","818":"AlleganSPI","819":"Provisional Death Counts for Coronavirus Disease (COVID-19)","820":"NNDSS - TABLE 1FF. Severe acute respiratory\u200b\u200b\u200b\u200b\u200b\u200b\u200b syndrome-associated coronavirus disease to Shigellosis","821":"Daily Census Tract-Level PM2.5 Concentrations, 2011-2015","822":"Daily Census Tract-Level PM2.5 Concentrations, 2006-2010","823":"Daily Census Tract-Level PM2.5 Concentrations, 2001-2005","824":"Daily Census Tract-Level Ozone Concentrations, 2011-2015","825":"Daily Census Tract-Level Ozone Concentrations, 2006-2010","826":"Daily Census Tract-Level Ozone Concentrations, 2001-2005","827":"NNDSS - TABLE 1JJ. Tuberculosis to Tularemia","828":"NNDSS - TABLE 1II. Tetanus to Trichinellosis","829":"NNDSS - TABLE 1OO. Viral hemorrhagic fevers, Machupo virus to Viral hemorrhagic fevers, Sabia virus","830":"NNDSS - TABLE 1T. Invasive pneumococcal disease, Age<5 years, Confirmed to Legionellosis","831":"NNDSS - TABLE 1V. Malaria to Measles, Indigenous","832":"NNDSS - Table 1F. Brucellosis to Candida auris, clinical","833":"NNDSS - Table 1E. Botulism, Foodborne to Botulism, Other (wound & unspecified)","834":"NNDSS - Table 1D. Arboviral diseases, Western equine encephalitis virus disease to Babesiosis","835":"NNDSS - Table 1C. Arboviral diseases, St. Louis encephalitis virus disease to West Nile virus disease","836":"NNDSS - Table 1B. Arboviral diseases, Jamestown Canyon virus disease to Powassan virus disease","837":"NNDSS - TABLE 1A. Anthrax to Arboviral diseases, Eastern equine encephalitis virus disease","838":"NNDSS - TABLE 1PP. Yellow fever to Zika virus disease, non-congenital","839":"NNDSS - TABLE 1NN. Viral hemorrhagic fevers, Junin virus to Viral hemorrhagic fevers, Lujo virus","840":"NNDSS - TABLE 1MM. Viral hemorrhagic fevers, Crimean-Congo hemorrhagic fever virus to Guanarito virus","841":"NNDSS - TABLE 1LL. Vibriosis, Confirmed to Vibriosis, Probable","842":"NNDSS - TABLE 1KK. Vancomycin-intermediate Staphylococcus aureus to Varicella morbidity","843":"NNDSS - TABLE 1HH. Syphilis, Congenital to Syphilis, Primary and Secondary","844":"NNDSS - TABLE 1GG. Smallpox to Streptococcal toxic shock syndrome","845":"NNDSS - TABLE 1FF. Severe acute respiratory syndrome-associated coronavirus disease to Shigellosis","846":"NNDSS - TABLE 1EE. Salmonella Paratyphi infection to Salmonellosis (excluding Salmonella Typhi infection and Salmonella Paratyphi infection)","847":"NNDSS - TABLE 1DD. Rubella to Rubella, congenital syndrome","848":"NNDSS - TABLE 1CC. Rabies, Animal to Rabies, Human","849":"NNDSS - TABLE 1BB. Q fever, Total to Q fever, Chronic","850":"NNDSS - TABLE 1AA. Poliovirus infection, nonparalytic to Psittacosis","851":"NNDSS - TABLE 1Z. Pertussis to Poliomyelitis, paralytic","852":"NNDSS - TABLE 1Y. Mumps to Novel influenza A virus infections","853":"NNDSS - TABLE 1X. Meningococcal disease, Other serogroups to Meningococcal disease, Unknown serogroup","854":"NNDSS - TABLE 1W. Meningococcal disease, All serogroups to Meningococcal disease, Serogroup B","855":"NNDSS - TABLE 1U. Leptospirosis to Listeriosis, Probable","856":"NNDSS - TABLE 1S. Invasive pneumococcal disease, all ages, Confirmed to Invasive pneumococcal disease, all ages, Probable","857":"NNDSS - TABLE 1P. Hemolytic uremic syndrome post-diarrheal to Hepatitis B, acute","858":"NNDSS - TABLE 1R. Hepatitis C, perinatal infection to Influenza-associated pediatric mortality","859":"NNDSS - TABLE 1Q. Hepatitis B, perinatal infection to Hepatitis C, acute, Probable","860":"NNDSS - TABLE 1O. Hansen's disease to Hantavirus pulmonary syndrome","861":"NNDSS - TABLE 1M. Gonorrhea to Haemophilus influenzae, invasive disease, Age <5 years, Serotype b","862":"NNDSS - TABLE 1L. Ehrlichiosis and Anaplasmosis, Ehrlichia ewingii infection to Giardiasis","863":"NNDSS - TABLE 1K. Ehrlichiosis and Anaplasmosis, Anaplasma phagocytophilum infection to Ehrlichia chaffeensis infection","864":"NNDSS - TABLE 1J. Dengue virus infections, Dengue to Severe dengue","865":"NNDSS - Table 1H.  Cholera to Coccidioidomycosis","866":"NNDSS - Table 1G. Carbapenemase-producing carbapenem-resistant Enterobacteriaceae to Chlamydia trachomatis infection","867":"NNDSS - Table 1I. Cryptosporidiosis to Cyclosporiasis","868":"500 Cities: City-level Data (GIS Friendly Format), 2018 release","869":"500 Cities: Local Data for Better Health, 2018 release","870":"500 Cities: Census Tract-level Data (GIS Friendly Format), 2018 release","871":"CDC STATE System E-Cigarette Legislation - Preemption Summary","872":"CDC STATE System E-Cigarette Legislation - Smokefree Indoor Air Summary","873":"U.S. Life Expectancy at Birth by State and Census Tract - 2010-2015","874":"Botulism","875":"NCHS - Drug Poisoning Mortality by County: United States","876":"NCHS - Drug Poisoning Mortality by State: United States","877":"NNDSS - Table II. Tuberculosis","878":"NNDSS - TABLE 1Y. Mumps to Novel influenza A virus infections","879":"NNDSS - TABLE 1PP. Yellow fever to Zika virus disease, non-congenital","880":"NNDSS - TABLE 1NN. Viral hemorrhagic fevers, Junin virus to Viral hemorrhagic fevers, Lujo virus","881":"NNDSS - TABLE 1MM. Viral hemorrhagic fevers, Crimean-Congo hemorrhagic fever virus to Guanarito virus","882":"NNDSS - TABLE 1LL. Vibriosis, Confirmed to Vibriosis, Probable","883":"NNDSS - TABLE 1KK. Vancomycin-resistant Staphylococcus aureus to Varicella morbidity","884":"NNDSS - TABLE 1JJ. Tularemia to  Vancomycin-intermediate Staphylococcus aureus","885":"NNDSS - TABLE 1II. Tetanus to Trichinellosis","886":"NNDSS - TABLE 1HH. Streptococcal toxic shock syndrome to Syphilis, Primary and Secondary","887":"NNDSS - TABLE 1GG. Spotted fever rickettsiosis, Confirmed to Smallpox","888":"NNDSS - TABLE 1FF. Severe acute respiratory syndrome-associated coronavirus disease to Shigellosis","889":"NNDSS - TABLE 1EE. Salmonella Paratyphi infection to Salmonellosis (excluding Salmonella Typhi infection and Salmonella Paratyphi infection)","890":"NNDSS - TABLE 1DD. Rubella to Rubella, congenital syndrome","891":"NNDSS - TABLE 1CC. Rabies, Animal to Rabies, Human","892":"NNDSS - TABLE 1BB. Q fever, Total to Q fever, Chronic","893":"NNDSS - TABLE 1AA.  Poliovirus infection, nonparalytic to Psittacosis","894":"NNDSS - TABLE 1Z. Pertussis to Poliomyelitis, paralytic","895":"NNDSS - TABLE 1X. Meningococcal disease,  Other serogroups to Meningococcal disease, Unknown serogroup","896":"NNDSS - TABLE 1W. Meningococcal disease, All serogroups to Meningococcal disease, Serogroup B","897":"NNDSS - TABLE 1V. Malaria to Measles, Imported","898":"NNDSS - TABLE 1U. Legionellosis to Listeriosis","899":"NNDSS - TABLE 1T. Invasive pneumococcal disease, age<5 , Confirmed to Invasive pneumococcal disease, age <5, Probable","900":"NNDSS - TABLE 1S. Invasive pneumococcal disease, all ages, Confirmed to Invasive pneumococcal disease, all ages, Probable","901":"NNDSS - TABLE 1R. Hepatitis C, perinatal infection to Influenza-associated pediatric mortality","902":"NNDSS - TABLE 1Q. Hepatitis B, perinatal infection to Hepatitis C (viral, acute), Probable","903":"NNDSS - TABLE 1P.  Hemolytic uremic syndrome post-diarrheal to Hepatitis (viral, acute, by type), B","904":"NNDSS - TABLE 1O.  Hansen's disease to Hantavirus pulmonary syndrome","905":"NNDSS - TABLE 1N. Haemophilus influenzae, invasive disease, (age <5 years), Non-b serotype to Unknown serotype","906":"NNDSS - TABLE 1M. Gonorrhea to Haemophilus influenzae, invasive disease (age <5 years), Serotype b","907":"NNDSS - TABLE 1L. Ehrlichiosis and Anaplasmosis, Ehrlichia ewingii infection to Giardiasis","908":"NNDSS - TABLE 1K. Ehrlichiosis and Anaplasmosis, Anaplasma phagocytophilum infection to Ehrlichia chaffeensis infection","909":"NNDSS - TABLE 1J. Dengue virus infections, Dengue to Severe dengue","910":"NNDSS - TABLE 1I. Cryptosporidiosis to Cyclosporiasis","911":"NNDSS - TABLE 1H. Cholera to Coccidioidomycosis","912":"NNDSS - TABLE 1G. Carbapenemase-producing carbapenem-resistant Enterobacteriaceae to Chancroid","913":"NNDSS - TABLE 1F. Brucellosis to Candida auris, clinical","914":"NNDSS - TABLE 1E. Botulism, Foodborne to Botulism, Other","915":"NNDSS - TABLE 1D. Arboviral diseases, West Nile virus to Babesiosis","916":"NNDSS - TABLE 1C. Arboviral diseases, St. Louis encephalitis virus to Western equine encephalitis virus","917":"NNDSS - Table 1B. Arboviral diseases, neuroinvasive and non-neuroinvasive, Jamestown Canyon virus disease to Powassan virus disease","918":"NNDSS - TABLE 1A. Anthrax to Arboviral diseases, Eastern equine encephalitis virus disease","919":"Tests for antibodies to trachoma PGP3 antigen","920":"NNDSS - TABLE 1PP. Yellow fever to Zika virus disease, non-congenital","921":"NNDSS - TABLE 1OO. Viral hemorrhagic fevers, Machupo virus to Viral hemorrhagic fevers, Sabia virus","922":"NNDSS - TABLE 1NN. Viral hemorrhagic fevers, Junin virus to Viral hemorrhagic fevers, Lujo virus","923":"NNDSS - TABLE 1MM. Viral hemorrhagic fevers, Crimean-Congo hemorrhagic fever virus to Guanarito virus","924":"NNDSS - TABLE 1LL. Vibriosis, Confirmed to Vibriosis, Probable","925":"NNDSS - TABLE 1KK. Vancomycin-resistant Staphylococcus aureus to Varicella morbidity","926":"NNDSS - TABLE 1JJ. Tularemia to  Vancomycin-intermediate Staphylococcus aureus","927":"NNDSS - TABLE 1II. Tetanus to Trichinellosis","928":"NNDSS - TABLE 1HH. Streptococcal toxic shock syndrome to Syphilis, Primary and Secondary","929":"NNDSS - TABLE 1GG. Spotted fever rickettsiosis, Confirmed to Smallpox","930":"NNDSS - TABLE 1FF. Severe acute respiratory syndrome-associated coronavirus disease to Shigellosis","931":"NNDSS - TABLE 1EE. Salmonella Paratyphi infection to Salmonellosis (excluding Salmonella Typhi infection and Salmonella Paratyphi infection)","932":"NNDSS - TABLE 1DD. Rubella to Rubella, congenital syndrome","933":"NNDSS - TABLE 1CC. Rabies, Animal to Rabies, Human","934":"NNDSS - TABLE 1BB. Q fever, Total to Q fever, Chronic","935":"NNDSS - TABLE 1AA.  Poliovirus infection, nonparalytic to Psittacosis","936":"NNDSS - TABLE 1Z. Pertussis to Poliomyelitis, paralytic","937":"NNDSS - TABLE 1Y. Mumps to Novel influenza A virus infections","938":"NNDSS - TABLE 1X. Meningococcal disease,  Other serogroups to Meningococcal disease, Unknown serogroup","939":"NNDSS - TABLE 1W. Meningococcal disease, All serogroups to Meningococcal disease, Serogroup B","940":"NNDSS - TABLE 1V. Malaria to Measles, Imported","941":"NNDSS - TABLE 1U. Legionellosis to Listeriosis","942":"NNDSS - TABLE 1T. Invasive pneumococcal disease, age<5 , Confirmed to Invasive pneumococcal disease, age <5, Probable","943":"NNDSS - TABLE 1S. Invasive pneumococcal disease, all ages, Confirmed to Invasive pneumococcal disease, all ages, Probable","944":"NNDSS - TABLE 1R. Hepatitis C, perinatal infection to Influenza-associated pediatric mortality","945":"NNDSS - TABLE 1Q. Hepatitis B, perinatal infection to Hepatitis C (viral, acute), Probable","946":"NNDSS - TABLE 1P.  Hemolytic uremic syndrome post-diarrheal to Hepatitis (viral, acute, by type), B","947":"NNDSS - TABLE 1O.  Hansen's disease to Hantavirus pulmonary syndrome","948":"NNDSS - TABLE 1N. Haemophilus influenzae, invasive disease, (age <5 years), Non-b serotype to Unknown serotype","949":"NNDSS - TABLE 1M. Gonorrhea to Haemophilus influenzae, invasive disease (age <5 years), Serotype b","950":"NNDSS - TABLE 1L. Ehrlichiosis and Anaplasmosis, Ehrlichia ewingii infection to Giardiasis","951":"NNDSS - TABLE 1K. Ehrlichiosis and Anaplasmosis, Anaplasma phagocytophilum infection to Ehrlichia chaffeensis infection","952":"NNDSS - TABLE 1J. Dengue virus infections, Dengue to Severe dengue","953":"NNDSS - TABLE 1I. Cryptosporidiosis to Cyclosporiasis","954":"NNDSS - TABLE 1H. Cholera to Coccidioidomycosis","955":"NNDSS - TABLE 1G. Carbapenemase-producing carbapenem-resistant Enterobacteriaceae to Chancroid","956":"NNDSS - TABLE 1F. Brucellosis to Candida auris, clinical","957":"NNDSS - TABLE 1E. Botulism, Foodborne to Botulism, Other","958":"NNDSS - TABLE 1D. Arboviral diseases, West Nile virus to Babesiosis","959":"NNDSS - TABLE 1C. Arboviral diseases, St. Louis encephalitis virus to Western equine encephalitis virus","960":"NNDSS - Table 1B. Arboviral diseases, Jamestown Canyon to Powassan","961":"NNDSS - TABLE 1A.  Anthrax to Arboviral diseases, Eastern equine encephalitis virus disease","962":"500 Cities: City-level Data (GIS Friendly Format), 2017 release","963":"500 Cities: Census Tract-level Data (GIS Friendly Format), 2017 release","964":"500 Cities: Local Data for Better Health, 2017 release","965":"Population-Weighted Ultraviolet Irradiance, 2004-2015","966":"Population-Weighted Global Horizontal Irradiance, 1991-2012","967":"United States Drought Monitor, 2000-2016","968":"Standardized Precipitation Index, 1895-2016","969":"Palmer Drought Severity Index, 1895-2016","970":"Daily Census Tract-Level PM2.5 Concentrations, 2011-2014","971":"Daily Census Tract-Level Ozone Concentrations, 2011-2014","972":"Daily Census Tract-Level PM2.5 Concentrations, 2006-2010","973":"Daily Census Tract-Level PM2.5 Concentrations, 2001-2005","974":"Standardized Precipitation Evapotranspiration Index, 1895-2016","975":"Daily Census Tract-Level Ozone Concentrations, 2001-2005","976":"Daily County-Level PM2.5 Concentrations, 2001-2014","977":"DHDS - Prevalence of Disability Status and Types by Demographic Groups, 2021","978":"DHDS - Prevalence of Disability Status and Types","979":"NNDSS - Table III. Tuberculosis","980":"NCHS - Injury Mortality: United States","981":"VSRR Provisional Drug Overdose Death Counts","982":"NCHS - Teen Birth Rates for Age Group 15-19 in the United States by County","983":"NNDSS - Table II. Carbapenemase-producing carbapenem-resistant Enterobacteriaceae","984":"NNDSS - Table II. Spotted fever rickettsiosis to Syphilis, primary and secondary","985":"NNDSS - Table II. West Nile to Zika","986":"NNDSS - Table II. Vibriosis","987":"NNDSS - Table II. Tetanus to Varicella","988":"NNDSS - Table II. Salmonellosis (excluding typhoid fever and paratyphoid fever) to Shigellosis","989":"NNDSS - Table II. Rabies, animal to Rubella, congenital syndrome","990":"NNDSS - Table II. Meningococcal disease to Pertussis","991":"NNDSS - Table II. Legionellosis to Malaria","992":"NNDSS - Table II. Invasive pneumococcal disease, age <5","993":"NNDSS - Table II. Invasive pneumococcal disease, all ages","994":"NNDSS - Table II. Hepatitis (viral, acute, by type) C","995":"NNDSS - Table II. Hepatitis (viral, acute, by type) A & B","996":"NNDSS - Table II. Giardiasis to Haemophilus influenza","997":"NNDSS - Table II. Ehrlichiosis and Anaplasmosis, Ehrlichia ewingii infection to Undetermined","998":"NNDSS - Table II. Ehrlichiosis and Anaplasmosis, Anaplasma phagocytophilum infection to Ehrlichia chaffeensis infection","999":"NNDSS - Table II. Cryptosporidiosis to Dengue virus infection","1000":"NNDSS - Table II. Chlamydia trachomatis infection to Coccidioidomycosis","1001":"NNDSS - Table II. Babesiosis to Campylobacteriosis","1002":"NNDSS - Table I. infrequently reported notifiable diseases","1003":"NCHS - Drug Poisoning Mortality by County: United States","1004":"NCHS - Drug Poisoning Mortality by State: United States","1005":"500 Cities: City-level Data (GIS Friendly Format), 2016 release","1006":"500 Cities: Census Tract-level Data (GIS Friendly Format), 2016 release","1007":"500 Cities: Local Data for Better Health, 2016 release","1008":"Table for STATE System Preemption on Licensure, Smokefree Indoor Air, and Youth Access Interactive Map","1009":"Table of States with Laws Requiring Licenses For Over-the-counter Sales of Cigarettes (CDC STATE System Tobacco Legislation - Licensure)","1010":"National Adult Tobacco Survey (NATS) Glossary and Methodology","1011":"Electronic Health Information Legal Epidemiology Protocol 2014","1012":"Electronic Health Information Legal Epidemiology Data Set 2014","1013":"CDC Library Subscription Databases","1014":"Top 12 Publishers of CDC Articles","1015":"Top 12 Science Clips Subject Headings","1016":"VSRR - State and National Provisional Counts for Live Births, Deaths, and Infant Deaths","1017":"Article Types","1018":"Cleared HIE Assessment Codebook Word","1019":"Animal Contact Exhibits_Legal Epidemiology Research Procedure and Code Book_2016","1020":"Disability and Health Data System (DHDS)","1021":"Science Clips","1022":"NNDSS - Table III. Tuberculosis","1023":"Adult Tobacco Consumption In The U.S., 2000-Present","1024":"NCHS - Potentially Excess Deaths from the Five Leading Causes of Death","1025":"NNDSS - Table II. West Nile virus disease","1026":"NNDSS - Table II. Tetanus to Varicella","1027":"NNDSS - Table II. Spotted Fever Rickettsiosis to Syphilis","1028":"NNDSS - Table II. Salmonellosis to Shigellosis","1029":"NNDSS - Table II. Rabies, animal to Rubella, congenital syndrome","1030":"NNDSS - Table II. Meningococcal to Pertussis","1031":"NNDSS - Table II. Legionellosis to Malaria","1032":"NNDSS - Table II. Invasive Pneumococcal Diseases, Age <5","1033":"NNDSS - Table II. Invasive Pneumococcal Diseases, All Ages","1034":"NNDSS - Table II. Hepatitis (viral, acute) C","1035":"NNDSS - Table II. Hepatitis (viral, acute) A & B","1036":"NNDSS - Table II. Giardiasis to Haemophilus influenza","1037":"NNDSS - Table II. Ehrlichiosis and Anaplasmosis","1038":"NNDSS - Table II. Cryptosporidiosis to Dengue","1039":"NNDSS - Table II. Chlamydia to Coccidioidomycosis","1040":"NNDSS - Table II. Babesiosis to Campylobacteriosis","1041":"NNDSS - Table I. infrequently reported notifiable diseases","1042":"US Census Methodology","1043":"US Census Annual Estimates of the Resident Population for Selected Age Groups by Sex for the United States","1044":"NCHS - VSRR Quarterly provisional estimates for infant mortality","1045":"500 Cities: Census Tract Boundaries","1046":"500 Cities: City Boundaries","1047":"NOHSS Adult Indicators - 2010 And Prior BRFSS","1048":"500 Cities: Census Tract-level Data (GIS Friendly Format), 2019 release","1049":"500 Cities: City-level Data (GIS Friendly Format), 2019 release","1050":"500 Cities: Local Data for Better Health, 2019 release","1051":"NCHS - Injury Mortality: United States","1052":"Deaths in 122 U.S. cities - 1962-2016. 122 Cities Mortality Reporting System","1053":"Deaths from Pneumonia and Influenza (P&I) and all deaths, by state and region, National Center For Health Statistics Mortality Surveillance System","1054":"NCHS - VSRR Quarterly provisional estimates for selected indicators of mortality","1055":"NCHS - VSRR Quarterly provisional estimates for selected birth indicators","1056":"Nutrition, Physical Activity, and Obesity - Youth Risk Behavior Surveillance System","1057":"Nutrition, Physical Activity, and Obesity - Women, Infant, and Child","1058":"Nutrition, Physical Activity, and Obesity - Policy and Environmental Data","1059":"Nutrition, Physical Activity, and Obesity - American Community Survey","1060":"Nutrition, Physical Activity, and Obesity - Behavioral Risk Factor Surveillance System","1061":"Nutrition, Physical Activity, and Obesity - National Immunization Survey (Breastfeeding)","1062":"Behavioral Risk Factors: Selected Metropolitan Area Risk Trends (SMART) MMSA Age-adjusted Prevalence Data (2011 to Present)","1063":"Behavioral Risk Factor Surveillance System (BRFSS) Age-Adjusted Prevalence Data (2011 to present)","1064":"Youth And Tobacco Use Infographic","1065":"Going Smokefree Matters - In Your Home Infographic","1066":"2022 Final Assisted Reproductive Technology (ART) Success Rates","1067":"2022 Final Assisted Reproductive Technology (ART) Patient and Cycle Characteristics","1068":"2022 Final Assisted Reproductive Technology (ART) Summary","1069":"2022 Final Assisted Reproductive Technology (ART) Services and Profiles","1070":"NNDSS - Table IV. Tuberculosis","1071":"NOHSS Adult Indicators - Adults who have visited a dentist or dental clinic in the past year","1072":"Going Smokefree Matters - Bars and Restaurants Infographic","1073":"Going Smokefree Matters - Casinos Infographic","1074":"TABLE III. Deaths in 122 U.S. cities","1075":"NNDSS - Table II. West Nile virus disease","1076":"NNDSS - Table II. Tetanus to Vibriosis","1077":"NNDSS - Table II. Spotted Fever Rickettsiosis to Syphilis","1078":"NNDSS - Table II. Shiga toxin to Shigellosis","1079":"NNDSS - Table II. Rubella to Salmonellosis","1080":"NNDSS - Table II. Mumps to Rabies, animal","1081":"NNDSS - Table II. Lyme disease to Meningococcal","1082":"NNDSS - Table II. Invasive Pneumococcal to Legionellosis","1083":"NNDSS - Table II. Hepatitis (viral, acute)","1084":"NNDSS - Table II. Giardiasis to Haemophilus influenza","1085":"NNDSS - Table II. Ehrlichiosis\/Anaplasmosis","1086":"NNDSS - Table II. Cryptosporidiosis to Dengue","1087":"NNDSS - Table II. Chlamydia to Coccidioidomycosis","1088":"NNDSS - Table II. Babesiosis to Campylobacteriosis","1089":"NNDSS - Table I. infrequently reported notifiable diseases","1090":"NCHS - Drug Poisoning Mortality by County: United States","1091":"NCHS - Drug Poisoning Mortality by State: United States","1092":"NCHS - Birth Rates for Females by Age Group: United States","1093":"NCHS - Pregnancy and Live Birth Rates, by Marital Status and Race and Hispanic Origin: United States, 1990-2010","1094":"NCHS - Nonmarital Birth Rates, by Age Group for All Women Age 15-44: United States, 1970-2013","1095":"NCHS - Birth Rates for Unmarried Women by Age, Race, and Hispanic Origin: United States","1096":"NCHS - Births to Unmarried Women by Age Group: United States","1097":"NCHS - Percent Distribution of Births to Unmarried Women by Age Group: United States","1098":"NCHS - Pregnancy Rates, by Age for Hispanic Women: United States, 1990-2010","1099":"NCHS - Teen Birth Rates for Females by Age Group, Race, and Hispanic Origin: United States","1100":"NCHS - Birth Rates for Women Aged 15-17, 17-18, and 15-19: United States, 1960-2015","1101":"NCHS - Natality Measures for Females by Hispanic Origin Subgroup: United States","1102":"NCHS - Natality Measures for Females by Race and Hispanic Origin: United States","1103":"NCHS - Percent Distribution of Births for Females by Age Group: United States","1104":"NCHS - Births and General Fertility Rates: United States","1105":"NCHS - Leading Causes of Death: United States","1106":"PONE-D-15-23803","1107":"Table of States with Laws Taxing E-Cigarettes (CDC STATE System E-Cigarette Legislation - Tax)","1108":"Table of States with Laws Prohibiting the Use of E-Cigarettes in Indoor Areas of Private Worksites, Restaurants, and Bars (CDC STATE System E-Cigarette Legislation - Smokefree Indoor Air)","1109":"Table of States with Laws Requiring Licenses For Over-the-counter Sales of E-Cigarettes (CDC STATE System E-Cigarette Legislation - Licensure)","1110":"Table of States with Laws Prohibiting Sales of E-Cigarettes to Minors (CDC STATE System E-Cigarette Legislation - Youth Access)","1111":"CDC STATE System E-Cigarette Legislation Glossary and Methodology","1112":"Smoking-Attributable Mortality, Morbidity, and Economic Costs (SAMMEC) - Smoking-Attributable Mortality (SAM)","1113":"Smoking-Attributable Mortality, Morbidity, and Economic Costs (SAMMEC) - Smoking-Attributable Mortality (SAM) Glossary and Methodology","1114":"Air Quality Measures on the National Environmental Health Tracking Network","1115":"NCHS - U.S. and State Trends on Teen Births","1116":"NCHS - Top Five Leading Causes of Death: United States, 1990, 1950, 2000","1117":"NCHS - Age-adjusted Death Rates for Selected Major Causes of Death","1118":"NCHS - Childhood Mortality Rates","1119":"NCHS - Infant Mortality Rates, by Race: United States, 1915-2013","1120":"NCHS - Infant and neonatal mortality rates: United States, 1915-2013","1121":"Table for STATE System Smokefree Indoor Air - Private Worksites, Restaurants, and Bars Interactive Map","1122":"NCHS - Death rates and life expectancy at birth","1123":"Table for STATE System Quitline Service Utilization - Incoming Calls per 10,000 State Population (NQDW OSH) Interactive Map","1124":"Table for STATE System Quitline Service Utilization - Callers Who Received Counseling and\/or Medications per 1,000 Callers (NQDW OSH) Interactive Map","1125":"Table for STATE System Expenditures as a Percentage of CDC Recommended Level  (UIC) Interactive Map","1126":"Table for STATE System Appropriations\/Grants Total Per Capita (UIC) Interactive Map","1127":"ASTDD Synopses of State Oral Health Programs - Number of health agencies serving large jurisdictions with a dental program directed by a dental professional with public health training","1128":"ASTDD Synopses of State Oral Health Programs - States with cleft lip\/palate registries and referral systems","1129":"ASTDD Synopses of State Oral Health Programs - States with dental directors or statewide oral health coalitions","1130":"Question Inventory on Tobacco (QIT)","1131":"Smoking-Attributable Mortality, Morbidity, and Economic Costs (SAMMEC) - Smoking-Attributable Expenditures (SAE) Glossary and Methodology","1132":"Behavioral Risk Factors: Selected Metropolitan Area Risk Trends (SMART) MMSA Prevalence Data (2010 and Prior)","1133":"Behavioral Risk Factors: Selected Metropolitan Area Risk Trends (SMART) County Prevalence Data (2010 and prior)","1134":"Behavioral Risk Factors: Selected Metropolitan Area Risk Trends (SMART) MMSA Prevalence Data (2011 to Present)","1135":"Behavioral Risk Factors: Selected Metropolitan Area Risk Trends (SMART) County Prevalence Data (2011 to 2012)","1136":"ASTDD Synopses of State Oral Health Programs - Selected indicators","1137":"Table for STATE System Comprehensive Medicaid Coverage of Cessation Treatments  Interactive Map","1138":"Table for STATE System Excise Taxes on Cigarettes Interactive Map","1139":"CDC STATE System E-Cigarette Legislation - Licensure","1140":"CDC STATE System E-Cigarette Legislation - Preemption","1141":"CDC STATE System E-Cigarette Legislation - Youth Access","1142":"CDC STATE System E-Cigarette Legislation - Smokefree Campus","1143":"CDC STATE System E-Cigarette Legislation - Tax","1144":"CDC STATE System E-Cigarette Legislation - Smokefree Indoor Air","1145":"Water Fluoridation - Percentage of PWS population who receive fluoridated water","1146":"NOHSS Adult Indicators","1147":"NOHSS Child Indicators","1148":"Water Fluoridation Statistics - Percent of PWS population receiving fluoridated water","1149":"NNDSS - Table IV. Tuberculosis","1150":"Division for Heart Disease and Stroke Prevention: Data Trends & Maps","1151":"Fatality Assessment and Control Evaluation (FACE) Program","1152":"CDC PRAMStat Data for 2000","1153":"CDC PRAMStat Data for 2001","1154":"CDC PRAMStat Data for 2002","1155":"CDC PRAMStat Data for 2003","1156":"CDC PRAMStat Data for 2004","1157":"2013-2014 PHAP Associates by State","1158":"CDC PRAMStat Data for 2005","1159":"CDC PRAMStat Data for 2006","1160":"CDC PRAMStat Data for 2007","1161":"CDC PRAMStat Data for 2008","1162":"CDC PRAMStat Data for 2009","1163":"Global Tobacco Surveillance System (GTSS) - Global Youth Tobacco Survey (GYTS)","1164":"Global Tobacco Surveillance System (GTSS) - Global Health Professions Student Survey (GHPSS)","1165":"Global Tobacco Surveillance System (GTSS) - Global School Personnel Survey (GSPS)","1166":"Global Tobacco Surveillance System (GTSS) - Global Adult Tobacco Survey (GATS)","1167":"CDC PRAMStat Data for 2010","1168":"CDC PRAMStat Data for 2011","1169":"LymeDisease_9211_county","1170":"Table of Smokefree Indoor Air for Private Worksites, Restaurants, and Bars (CDC STATE System Tobacco Legislation- Smokefree Indoor Air)","1171":"Quitline Glossary and Methodology","1172":"Behavior Risk Factor Surveillance System (BRFSS) Glossary and Methodology","1173":"University of Illinois at Chicago Health Policy Center - Funding Glossary and Methodology","1174":"The Tax Burden on Tobacco Glossary and Methodology","1175":"CDC Best Practices for Comprehensive Tobacco Control Programs - 2007 Glossary and Methodology","1176":"CDC Best Practices for Comprehensive Tobacco Control Programs - 2014 Glossary and Methodology","1177":"NAAG Tobacco Settlement Payments Glossary and Methodology","1178":"SAMHSA Synar Reports: Youth Tobacco Sales Glossary and Methodology","1179":"CDC STATE System Tobacco Legislation Glossary and Methodology","1180":"Medicaid Coverage Of Cessation Treatments And Barriers To Treatments Glossary and Methodology","1181":"Smoking-Attributable Mortality, Morbidity, and Economic Costs (SAMMEC) - Smoking-Attributable Expenditures (SAE)","1182":"Table of Preemption on Youth Access (CDC STATE System Tobacco Legislation - Preemption)","1183":"Table of Preemption on Smokefree Indoor Air (CDC STATE System Tobacco Legislation - Preemption)","1184":"Table of Smokefree Non-Tribal Gaming Facilities (CDC STATE System Tobacco Legislation- Smokefree Indoor Air)","1185":"NNDSS - Table II. Ehrlichiosis\/Anaplasmosis","1186":"NNDSS - Table I. infrequently reported notifiable diseases","1187":"TABLE III. Deaths in 122 U.S. cities","1188":"NNDSS - Table II. West Nile virus disease","1189":"NNDSS - Table II. Tetanus to Vibriosis","1190":"NNDSS - Table II. Spotted Fever Rickettsiosis to Syphilis","1191":"NNDSS - Table II. Shiga toxin to Shigellosis","1192":"NNDSS - Table II. Rubella to Salmonellosis","1193":"NNDSS - Table II. Mumps to Rabies, animal","1194":"NNDSS - Table II. Lyme disease to Meningococcal","1195":"NNDSS - Table II. Invasive Pneumococcal to Legionellosis","1196":"NNDSS - Table II. Hepatitis (viral, acute)","1197":"NNDSS - Table II. Giardiasis to Haemophilus influenza","1198":"NNDSS - Table II. Cryptosporidiosis to Dengue","1199":"NNDSS - Table II. Chlamydia to Coccidioidomycosis","1200":"NNDSS - Table II. Babesiosis to Campylobacteriosis","1201":"Table of Gross Cigarette Tax Revenue Per State (Orzechowski and Walker Tax Burden on Tobacco)","1202":"Table of Medicaid Coverage of Treatments \u2013 Medications (Lung Association Cessation Coverage)","1203":"Percentage of Drivers and Front Seat Passengers Wearing Seat Belts, 2012 & 2014, Region 10 - Seattle","1204":"Percentage of Drivers and Front Seat Passengers Wearing Seat Belts, 2012 & 2014, Region 9 - San Francisco","1205":"Percentage of Drivers and Front Seat Passengers Wearing Seat Belts, 2012 & 2014, Region 8 - Denver","1206":"Percentage of Drivers and Front Seat Passengers Wearing Seat Belts, 2012 & 2014, Region 7 - Kansas City","1207":"Percentage of Drivers and Front Seat Passengers Wearing Seat Belts, 2012 & 2014, Region 6 - Dallas","1208":"Percentage of Drivers and Front Seat Passengers Wearing Seat Belts, 2012 & 2014, Region 5 - Chicago","1209":"Percentage of Drivers and Front Seat Passengers Wearing Seat Belts, 2012 & 2014, Region 4 - Atlanta","1210":"Percentage of Drivers and Front Seat Passengers Wearing Seat Belts, 2012 & 2014, Region 3 - Philadelphia","1211":"Percentage of Drivers and Front Seat Passengers Wearing Seat Belts, 2012 & 2014, Region 2 - New York","1212":"Percentage of Drivers and Front Seat Passengers Wearing Seat Belts, 2012 & 2014, Region 1 - Boston","1213":"Percentage of Adults Who Report Driving After Drinking Too Much (in the past 30 days), 2012 & 2014,  Region 10 - Seattle","1214":"Percentage of Adults Who Report Driving After Drinking Too Much (in the past 30 days), 2012 & 2014, Region 9 - San Francisco","1215":"Percentage of Adults Who Report Driving After Drinking Too Much (in the past 30 days), 2012 & 2014, Region 8 - Denver","1216":"Percentage of Adults Who Report Driving After Drinking Too Much (in the past 30 days),  2012 & 2014, Region 7 - Kansas City","1217":"Percentage of Adults Who Report Driving After Drinking Too Much (in the past 30 days), 2012 & 2014, Region 6 - Dallas","1218":"Percentage of Adults Who Report Driving After Drinking Too Much (in the past 30 days), 2012 & 2014, Region 5 - Chicago","1219":"Percentage of Adults Who Report Driving After Drinking Too Much (in the past 30 days),  2012 & 2014, Region 4 - Atlanta","1220":"Percentage of Adults Who Report Driving After Drinking Too Much (in the past 30 days), 2012 & 2014, Region 3 - Philadelphia","1221":"Percentage of Adults Who Report Driving After Drinking Too Much (in the past 30 days), 2012 & 2014, Region 2 - New York","1222":"Percentage of Adults Who Report Driving After Drinking Too Much (in the past 30 days), 2012 & 2014, Region 1 - Boston","1223":"Impaired Driving Death Rate, by Age and Gender, 2012 & 2014, Region 10 - Seattle","1224":"Impaired Driving Death Rate, by Age and Gender, 2012 & 2014, Region 9 - San Francisco","1225":"Impaired Driving Death Rate, by Age and Gender, 2012 & 2014, Region 8 - Denver","1226":"Impaired Driving Death Rate, by Age and Gender, 2012 & 2014, Region 7 - Kansas City","1227":"Impaired Driving Death Rate, by Age and Gender, 2012 & 2014, Region 6 - Dallas","1228":"Impaired Driving Death Rate, by Age and Gender, 2012 & 2014, Region 5 - Chicago","1229":"Impaired Driving Death Rate, by Age and Gender, 2012 & 2014, Region 4 - Atlanta","1230":"Impaired Driving Death Rate, by Age and Gender, 2012 & 2014, Region 3 - Philadelphia","1231":"Impaired Driving Death Rate, by Age and Gender, 2012 & 2014, Region 2 - New York","1232":"Impaired Driving Death Rate, by Age and Gender, 2012 & 2014, Region 1 - Boston","1233":"CDC STATE System Tobacco Legislation - Smokefree Indoor Air Summary","1234":"CDC STATE System Tobacco Legislation - Preemption Summary","1235":"Motor Vehicle Occupant Death Rate, by Age and Gender, 2012 & 2014,  Region 10 - Seattle","1236":"Motor Vehicle Occupant Death Rate, by Age and Gender, 2012 & 2014,  Region 9 - San Francisco","1237":"Motor Vehicle Occupant Death Rate, by Age and Gender, 2012 & 2014, Region 8 - Denver","1238":"Motor Vehicle Occupant Death Rate, by Age and Gender, 2012 & 2014, Region 7 - Kansas City","1239":"Motor Vehicle Occupant Death Rate, by Age and Gender, 2012 & 2014, Region 6 - Dallas","1240":"Motor Vehicle Occupant Death Rate, by Age and Gender, 2012 & 2014, Region 5 - Chicago","1241":"Motor Vehicle Occupant Death Rate, by Age and Gender, 2012 & 2014, Region 4 - Atlanta","1242":"Motor Vehicle Occupant Death Rate, by Age and Gender, 2012 & 2014, Region 3 - Philadelphia","1243":"Motor Vehicle Occupant Death Rate, by Age and Gender, 2012 & 2014, Region 2 - New York","1244":"Motor Vehicle Occupant Death Rate, by Age and Gender, 2012 & 2014, HHS Region 1 - Boston","1245":"Percentage of Adults Who Report Driving After Drinking Too Much (in the past 30 days), All States, 2012 & 2014","1246":"Percentage of Drivers and Front Seat Passengers Wearing Seat Belts, 2012 & 2014, All States","1247":"Impaired Driving Death Rate, by Age and Gender, 2012 & 2014, All States","1248":"Occupant and Alcohol-Impaired Driving Deaths in States, 2005-2014","1249":"Motor Vehicle Occupant Death Rate, by Age and Gender, 2012 & 2014, All States","1250":"Table of Recommended Funding Levels by Program Components (CDC Best Practices for Comprehensive Tobacco Control Programs 2014)","1251":"Quitline \u2013 Services Available \u2013 Medications - 2010 To Present","1252":"Quitline \u2013 Services Available \u2013 Hours Of Operation And Available Languages - 2010 To Present","1253":"Quitline \u2013 Services Available \u2013 Counseling - 2010 To Present","1254":"Quitline \u2013 Service Utilization - 2010 To Present","1255":"Quitline \u2013 7-Month Follow-Up (Not Comparable Across States) \u2013 2010-2011","1256":"Quitline \u2013 Quitline Names and Phone Numbers","1257":"New Chikungunya Cases Reported in the Americas","1258":"Nowcast Predictions for Chikungunya Virus-Infected Travelers","1259":"University of Illinois at Chicago Health Policy Center - Funding","1260":"Nowcast Predictions for Local Transmission of Chikungunya Virus","1261":"Table of Excise Taxes on Non-Combustible Tobacco Products (CDC STATE System Tobacco Legislation - Tax)","1262":"Table of Excise Taxes on Combustible Tobacco Products (CDC STATE System Tobacco Legislation - Tax)","1263":"Table of Preemption on Licensure (CDC STATE System Tobacco Legislation - Preemption)","1264":"Table of Licensure for Vending Machines (CDC STATE System Tobacco Legislation)","1265":"CDC STATE System Tobacco Legislation - Smokefree Indoor Air","1266":"CDC STATE System Tobacco Legislation - Smokefree Campus","1267":"CDC STATE System Tobacco Legislation - Preemption","1268":"CDC STATE System Tobacco Legislation - Licensure","1269":"CDC STATE System Tobacco Legislation - Youth Access","1270":"YRBS State Tobacco Variables  2013 - v2","1271":"CDC STATE System Tobacco Legislation - Tax","1272":"Healthy People 2020 Tobacco Use Objectives","1273":"Table of Recommended Per-Capita Funding Levels for State Programs (CDC Best Practices for Comprehensive Tobacco Control Programs 2014)","1274":"Table of Recommended Total Funding Levels for State Programs (CDC Best Practices for Comprehensive Tobacco Control Programs 2014)","1275":"NAAG Tobacco Settlement Payments","1276":"The Tax Burden on Tobacco, 1970-2019","1277":"SAMHSA Synar Reports: Youth Tobacco Sales","1278":"Table of Medicaid Barriers to Treatments (Lung Association Cessation Coverage)","1279":"Table of Medicaid Coverage of Treatments \u2013 Counseling (Lung Association Cessation Coverage)","1280":"Table of Comprehensive Medicaid Coverage of Treatments (Lung Association Cessation Coverage)","1281":"Table of Medicaid Coverage of Treatments (Lung Association Cessation Coverage)","1282":"CDC Best Practices for Comprehensive Tobacco Control Programs - 2014","1283":"CDC Best Practices for Comprehensive Tobacco Control Programs - 2007","1284":"Medicaid Coverage Of Cessation Treatments And Barriers To Treatments","1285":"Top syndicated pages from CDC.gov by weekly page views","1286":"NNDSS - Table IV. Tuberculosis","1287":"Rates of TBI-related Emergency Department Visits, Hospitalizations, and Deaths by Sex - United States, 2001 \u2013 2010","1288":"Rates of TBI-related Emergency Department Visits, Hospitalizations, and Deaths - United States, 2001 \u2013 2010","1289":"Rates of TBI-related Deaths by Age Group - United States, 2001 - 2010","1290":"NNDSS - Table I. infrequently reported notifiable diseases","1291":"NNDSS - Table II. Varicella to West Nile virus disease","1292":"NNDSS - Table II. Spotted Fever Rickettsiosis to Syphilis","1293":"NNDSS - Table II. Salmonellosis to Shigellosis","1294":"NNDSS - Table II. Mumps to Rabies, animal","1295":"NNDSS - Table II. Lyme disease to Meningococcal","1296":"NNDSS - Table II. Invasive Pneumococcal to Legionellosis","1297":"NNDSS - Table II. Hepatitis (viral, acute)","1298":"NNDSS - Table II. Giardiasis to Haemophilus influenza","1299":"NNDSS - Table II. Ehrlichiosis\/Anaplasmosis","1300":"NNDSS - Table II. Cryptosporidiosis to Dengue Hemorrhagic Fever","1301":"NNDSS - Table II. Babesiosis to Coccidioidomycosis","1302":"BRFSS Prevalence And Trends Data: Health Care Access\/Coverage for 2011","1303":"BRFSS Prevalence and Trends Data: Tobacco Use - Four Level Smoking Data for 2011","1304":"Selected Trend Table from Health, United States, 2011. Vaccination coverage among children 19 - 35 months of age for selected diseases, by race, Hispanic origin, poverty level, and location of residence in metropolitan statistical area: United States, sel","1305":"Selected Trend Table from Health, United States, 2011. Diabetes prevalence and glycemic control among adults 20 years of age and over, by sex, age, and race and Hispanic origin: United States, selected years 1988 - 1994 through 2003 - 2006","1306":"Selected Trend Table from Health, United States, 2011. Leading causes of death and numbers of deaths, by sex, race, and Hispanic origin: United States, 1980 and 2009","1307":"Selected Trend Table from Health, United States, 2011. Low birthweight live births, by race and Hispanic origin of mother, and state: United States, 2000 - 2002, 2003 - 2005, and 2006 - 2008","1308":"Selected Trend Table from Health, United States, 2011. Health conditions among children under 18 years of age, by selected characteristics: United States, average annual, selected years 1997 - 1999 through 2008 - 2010","1309":"BRFSS Prevalence And Trends Data: Health Care Access\/Coverage for 1995-2010","1310":"CDC.gov metrics hits by year","1311":"Monthly Page Views to CDC.gov","1312":"State Specific Influenza Vaccination Coverage Among Women With Live Birth- PRAMS, 2009-10 Influenza Season","1313":"BRFSS Prevalence and Trends Data: Tobacco Use - Four Level Smoking Data for 1995-2010","1314":"BRFSS Prevalence And Trends Data: Tobacco Use - Adults Who Are Current Smokers for 1995-2010"}}